500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Morgan AR, Touchard S, Leckey C, O'Hagan C, Nevado-Holgado AJ, Barkhof F, Bertram L, Blin O, Bos I, Dobricic V, Engelborghs S, Frisoni G, Frölich L, Gabel S, et al. Inflammatory biomarkers in Alzheimer's disease plasma. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31047856 DOI: 10.1016/j.jalz.2019.03.007  1
2019 Leeuwis AE, Weaver NA, Biesbroek JM, Exalto LG, Kuijf HJ, Hooghiemstra AM, Prins ND, Scheltens P, Barkhof F, van der Flier WM, Biessels GJ. Impact of white matter hyperintensity location on depressive symptoms in memory-clinic patients: a lesion–symptom mapping study Journal of Psychiatry & Neuroscience : Jpn. 44: 1-10. PMID 31021068 DOI: 10.1503/jpn.180136  1
2019 van Maurik IS, Slot RER, Verfaillie SCJ, Zwan MD, Bouwman FH, Prins ND, Teunissen CE, Scheltens P, Barkhof F, Wattjes MP, Molinuevo JL, Rami L, Wolfsgruber S, Peters O, Jessen F, et al. Personalized risk for clinical progression in cognitively normal subjects-the ABIDE project. Alzheimer's Research & Therapy. 11: 33. PMID 30987684 DOI: 10.1186/s13195-019-0487-y  1
2019 Dicks E, Vermunt L, van der Flier WM, Visser PJ, Barkhof F, Scheltens P, Tijms BM. Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease. Neuroimage. Clinical. 22: 101786. PMID 30921610 DOI: 10.1016/j.nicl.2019.101786  1
2019 Boomsma JMF, Exalto LG, Barkhof F, Berg EVD, Bresser J, Heinen R, Leeuwis AE, Prins ND, Scheltens P, Weinstein HC, van der Flier WM, Biessels GJ. How Do Different Forms of Vascular Brain Injury Relate to Cognition in a Memory Clinic Population: The TRACE-VCI Study. Journal of Alzheimer's Disease : Jad. PMID 30909212 DOI: 10.3233/JAD-180696  1
2019 Kuijf HJ, Biesbroek JM, de Bresser J, Heinen R, Andermatt S, Bento M, Berseth M, Belyaev M, Cardoso MJ, Casamitjana A, Collins DL, Dadar M, Georgiou A, Ghafoorian M, Jin D, ... ... Barkhof F, et al. Standardized Assessment of Automatic Segmentation of White Matter Hyperintensities; Results of the WMH Segmentation Challenge. Ieee Transactions On Medical Imaging. PMID 30908194 DOI: 10.1109/TMI.2019.2905770  0.52
2019 d'Ambrosio A, Valsasina P, Gallo A, De Stefano N, Pareto D, Barkhof F, Ciccarelli O, Enzinger C, Tedeschi G, Stromillo ML, Arévalo MJ, Hulst HE, Muhlert N, Koini M, Filippi M, et al. Reduced dynamics of functional connectivity and cognitive impairment in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519837707. PMID 30887862 DOI: 10.1177/1352458519837707  0.8
2019 Smith LA, Melbourne A, Owen D, Cardoso MJ, Sudre CH, Tillin T, Sokolska M, Atkinson D, Chaturvedi N, Ourselin S, Hughes AD, Barkhof F, Jäger HR. Cortical cerebral blood flow in ageing: effects of haematocrit, sex, ethnicity and diabetes. European Radiology. PMID 30887200 DOI: 10.1007/s00330-019-06096-w  0.32
2019 Bos I, Vos S, Verhey F, Scheltens P, Teunissen C, Engelborghs S, Sleegers K, Frisoni G, Blin O, Richardson JC, Bordet R, Tsolaki M, Popp J, Peyratout G, Martinez-Lage P, ... ... Barkhof F, et al. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30853464 DOI: 10.1016/j.jalz.2019.01.004  1
2019 Ferro DA, van den Brink H, Exalto LG, Boomsma JMF, Barkhof F, Prins ND, van der Flier WM, Biessels GJ. Clinical relevance of acute cerebral microinfarcts in vascular cognitive impairment. Neurology. PMID 30850444 DOI: 10.1212/WNL.0000000000007250  1
2019 Koikkalainen JR, Rhodius-Meester HFM, Frederiksen KS, Bruun M, Hasselbalch SG, Baroni M, Mecocci P, Vanninen R, Remes A, Soininen H, van Gils M, van der Flier WM, Scheltens P, Barkhof F, Erkinjuntti T, et al. Automatically computed rating scales from MRI for patients with cognitive disorders. European Radiology. PMID 30796570 DOI: 10.1007/s00330-019-06067-1  1
2019 Groeneveld ON, Moneti C, Heinen R, de Bresser J, Kuijf HJ, Exalto LG, Boomsma JMF, Kappelle LJ, Barkhof F, Prins ND, Scheltens P, van der Flier WM, Biessels GJ. The Clinical Phenotype of Vascular Cognitive Impairment in Patients with Type 2 Diabetes Mellitus. Journal of Alzheimer's Disease : Jad. PMID 30775988 DOI: 10.3233/JAD-180914  1
2019 Bruun M, Koikkalainen J, Rhodius-Meester HFM, Baroni M, Gjerum L, van Gils M, Soininen H, Remes AM, Hartikainen P, Waldemar G, Mecocci P, Barkhof F, Pijnenburg Y, van der Flier WM, Hasselbalch SG, et al. Detecting frontotemporal dementia syndromes using MRI biomarkers. Neuroimage. Clinical. 22: 101711. PMID 30743135 DOI: 10.1016/j.nicl.2019.101711  1
2019 Jonkman LE, Graaf YG, Bulk M, Kaaij E, Pouwels PJW, Barkhof F, Rozemuller AJM, van der Weerd L, Geurts JJG, van de Berg WDJ. Normal Aging Brain Collection Amsterdam (NABCA): A comprehensive collection of postmortem high-field imaging, neuropathological and morphometric datasets of non-neurological controls. Neuroimage. Clinical. 22: 101698. PMID 30711684 DOI: 10.1016/j.nicl.2019.101698  0.88
2019 Salvadó G, Brugulat-Serrat A, Sudre CH, Grau-Rivera O, Suárez-Calvet M, Falcon C, Fauria K, Cardoso MJ, Barkhof F, Molinuevo JL, Gispert JD. Spatial patterns of white matter hyperintensities associated with Alzheimer's disease risk factors in a cognitively healthy middle-aged cohort. Alzheimer's Research & Therapy. 11: 12. PMID 30678723 DOI: 10.1186/s13195-018-0460-1  0.32
2019 Müller DMJ, Robe PAJT, Eijgelaar RS, Witte MG, Visser M, de Munck JC, Broekman MLD, Seute T, Hendrikse J, Noske DP, Vandertop WP, Barkhof F, Kouwenhoven MCM, Mandonnet E, Berger MS, et al. Comparing Glioblastoma Surgery Decisions Between Teams Using Brain Maps of Tumor Locations, Biopsies, and Resections. Jco Clinical Cancer Informatics. 1-12. PMID 30673344 DOI: 10.1200/CCI.18.00089  0.6
2019 Amiri H, Brouwer I, Kuijer JPA, de Munck JC, Barkhof F, Vrenken H. Novel imaging phantom for accurate and robust measurement of brain atrophy rates using clinical MRI. Neuroimage. Clinical. 21: 101667. PMID 30665101 DOI: 10.1016/j.nicl.2019.101667  0.88
2019 Emanuel AL, van Duinkerken E, Wattjes MP, Klein M, Barkhof F, Snoek FJ, Diamant M, Eringa EC, IJzerman RG, Serné EH. The presence of cerebral white matter lesions and lower skin microvascular perfusion predict lower cognitive performance in type 1 diabetes patients with retinopathy but not in healthy controls - a longitudinal study. Microcirculation (New York, N.Y. : 1994). e12530. PMID 30659710 DOI: 10.1111/micc.12530  0.84
2019 Oudega ML, van der Werf YD, Dols A, Wattjes MP, Barkhof F, Bouckaert F, Vandenbulcke M, De Winter FL, Sienaert P, Eikelenboom P, Stek ML, van den Heuvel OA, Emsell L, Rhebergen D, van Exel E. Exploring resting state connectivity in patients with psychotic depression. Plos One. 14: e0209908. PMID 30653516 DOI: 10.1371/journal.pone.0209908  0.84
2018 Rhodius-Meester HFM, Liedes H, Koikkalainen J, Wolfsgruber S, Coll-Padros N, Kornhuber J, Peters O, Jessen F, Kleineidam L, Molinuevo JL, Rami L, Teunissen CE, Barkhof F, Sikkes SAM, Wesselman LMP, et al. Computer-assisted prediction of clinical progression in the earliest stages of AD. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 726-736. PMID 30619929 DOI: 10.1016/j.dadm.2018.09.001  1
2018 Gasperini C, Prosperini L, Tintoré M, Sormani MP, Filippi M, Rio J, Palace J, Rocca MA, Ciccarelli O, Barkhof F, Sastre-Garriga J, Vrenken H, Frederiksen JL, Yousry TA, Enzinger C, et al. Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge. Neurology. PMID 30587516 DOI: 10.1212/WNL.0000000000006810  0.8
2018 Jutten RJ, Dicks E, Vermaat L, Barkhof F, Scheltens P, Tijms BM, Sikkes SAM. Impairment in complex activities of daily living is related to neurodegeneration in Alzheimer's disease-specific regions. Neurobiology of Aging. 75: 109-116. PMID 30557769 DOI: 10.1016/j.neurobiolaging.2018.11.018  1
2018 Legdeur N, Badissi M, Carter SF, de Crom S, van de Kreeke A, Vreeswijk R, Trappenburg MC, Oudega ML, Koek HL, van Campen JP, Keijsers CJPW, Amadi C, Hinz R, Gordon MF, Novak G, ... ... Barkhof F, et al. Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study. Bmc Geriatrics. 18: 289. PMID 30477432 DOI: 10.1186/s12877-018-0984-z  1
2018 Hagens MHJ, Golla SV, Wijburg MT, Yaqub M, Heijtel D, Steenwijk MD, Schober P, Brevé JJP, Schuit RC, Reekie TA, Kassiou M, van Dam AM, Windhorst AD, Killestein J, Barkhof F, et al. In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [F]DPA714 PET. Journal of Neuroinflammation. 15: 314. PMID 30424780 DOI: 10.1186/s12974-018-1352-9  0.8
2018 Hendriks EJ, Idema S, Hervey-Jumper SL, Bernat AL, Zwinderman AH, Barkhof F, Vandertop WP, Mandonnet E, Duffau H, Berger MS, De Witt Hamer PC. Preoperative Resectability Estimates of Nonenhancing Glioma by Neurosurgeons and a Resection Probability Map. Neurosurgery. PMID 30423155 DOI: 10.1093/neuros/nyy487  0.44
2018 Ten Kate M, Ingala S, Schwarz AJ, Fox NC, Chételat G, van Berckel BNM, Ewers M, Foley C, Gispert JD, Hill D, Irizarry MC, Lammertsma AA, Molinuevo JL, Ritchie C, Scheltens P, ... ... Barkhof F, et al. Secondary prevention of Alzheimer's dementia: neuroimaging contributions. Alzheimer's Research & Therapy. 10: 112. PMID 30376881 DOI: 10.1186/s13195-018-0438-z  1
2018 Sudre CH, Smith L, Atkinson D, Chaturvedi N, Ourselin S, Barkhof F, Hughes AD, Jäger HR, Cardoso MJ. Cardiovascular Risk Factors and White Matter Hyperintensities: Difference in Susceptibility in South Asians Compared With Europeans. Journal of the American Heart Association. 7: e010533. PMID 30376748 DOI: 10.1161/JAHA.118.010533  0.32
2018 Ten Kate M, Dicks E, Visser PJ, van der Flier WM, Teunissen CE, Barkhof F, Scheltens P, Tijms BM. Atrophy subtypes in prodromal Alzheimer's disease are associated with cognitive decline. Brain : a Journal of Neurology. PMID 30351346 DOI: 10.1093/brain/awy264  1
2018 Groot C, Sudre CH, Barkhof F, Teunissen CE, van Berckel BNM, Seo SW, Ourselin S, Scheltens P, Cardoso MJ, van der Flier WM, Ossenkoppele R. Clinical phenotype, atrophy, and small vessel disease in ε2 carriers with Alzheimer disease. Neurology. PMID 30341156 DOI: 10.1212/WNL.0000000000006503  1
2018 Frisoni GB, Barkhof F, Altomare D, Berkhof J, Boccardi M, Canzoneri E, Collij L, Drzezga A, Farrar G, Garibotto V, Gismondi R, Gispert JD, Jessen F, Kivipelto M, Alves IL, et al. AMYPAD Diagnostic and Patient Management Study: Rationale and design. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30339801 DOI: 10.1016/j.jalz.2018.09.003  1
2018 van de Kreeke JA, Nguyen HT, Konijnenberg E, Tomassen J, den Braber A, Ten Kate M, Sudre CH, Barkhof F, Boomsma DI, Tan HS, Verbraak FD, Visser PJ. Retinal and Cerebral Microvasculopathy: Relationships and Their Genetic Contributions. Investigative Ophthalmology & Visual Science. 59: 5025-5031. PMID 30326071 DOI: 10.1167/iovs.18-25341  0.84
2018 Hu X, Teunissen C, Spottke A, Heneka MT, Düzel E, Peters O, Li S, Priller J, Bürger K, Teipel S, Laske C, Verfaillie S, Barkhof F, Coll-Padrós N, Rami L, et al. Smaller medial temporal lobe volumes in individuals with subjective cognitive decline and biomarker evidence of Alzheimer's disease-Data from three memory clinic studies. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30321506 DOI: 10.1016/j.jalz.2018.09.002  0.6
2018 Bruun M, Rhodius-Meester HFM, Koikkalainen J, Baroni M, Gjerum L, Lemstra AW, Barkhof F, Remes AM, Urhemaa T, Tolonen A, Rueckert D, van Gils M, Frederiksen KS, Waldemar G, Scheltens P, et al. Evaluating combinations of diagnostic tests to discriminate different dementia types. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 509-518. PMID 30320203 DOI: 10.1016/j.dadm.2018.07.003  1
2018 Collij L, Konijnenberg E, Reimand J, Ten Kate M, Den Braber A, Lopes Alves I, Zwan M, Yaqub M, Van Assema D, Wink AM, Lammertsma A, Scheltens P, Visser PJ, Barkhof F, Van Berckel B. Assessing Amyloid Pathology in Cognitively Normal Subjects using [F]Flutemetamol PET: Comparing Visual Reads and Quantitative Methods. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30315145 DOI: 10.2967/jnumed.118.211532  1
2018 Leeuwis AE, Smith LA, Melbourne A, Hughes AD, Richards M, Prins ND, Sokolska M, Atkinson D, Tillin T, Jäger HR, Chaturvedi N, van der Flier WM, Barkhof F. Cerebral Blood Flow and Cognitive Functioning in a Community-Based, Multi-Ethnic Cohort: The SABRE Study. Frontiers in Aging Neuroscience. 10: 279. PMID 30279656 DOI: 10.3389/fnagi.2018.00279  1
2018 Rocca MA, Barkhof F, De Luca J, Frisén J, Geurts JJG, Hulst HE, Sastre-Garriga J, Filippi M. The hippocampus in multiple sclerosis. The Lancet. Neurology. 17: 918-926. PMID 30264730 DOI: 10.1016/S1474-4422(18)30309-0  0.88
2018 Ten Kate M, Redolfi A, Peira E, Bos I, Vos SJ, Vandenberghe R, Gabel S, Schaeverbeke J, Scheltens P, Blin O, Richardson JC, Bordet R, Wallin A, Eckerstrom C, Molinuevo JL, ... ... Barkhof F, et al. MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study. Alzheimer's Research & Therapy. 10: 100. PMID 30261928 DOI: 10.1186/s13195-018-0428-1  1
2018 Ostrowitzki S, Lasser RA, Dorflinger E, Scheltens P, Barkhof F, Nikolcheva T, Ashford E, Retout S, Hofmann C, Delmar P, Klein G, Andjelkovic M, Dubois B, Boada M, Blennow K, et al. Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease. Alzheimer's Research & Therapy. 10: 99. PMID 30261916 DOI: 10.1186/s13195-018-0409-4  1
2018 Eijlers AJC, van Geest Q, Dekker I, Steenwijk MD, Meijer KA, Hulst HE, Barkhof F, Uitdehaag BMJ, Schoonheim MM, Geurts JJG. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study. Brain : a Journal of Neurology. 141: 2605-2618. PMID 30169585 DOI: 10.1093/brain/awy202  0.88
2018 Bendfeldt K, Taschler B, Gaetano L, Madoerin P, Kuster P, Mueller-Lenke N, Amann M, Vrenken H, Wottschel V, Barkhof F, Borgwardt S, Klöppel S, Wicklein EM, Kappos L, Edan G, et al. MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry. Brain Imaging and Behavior. PMID 30155789 DOI: 10.1007/s11682-018-9942-9  0.8
2018 Wink AM, Tijms BM, Ten Kate M, Raspor E, de Munck JC, Altena E, Ecay-Torres M, Clerigue M, Estanga A, Garcia-Sebastian M, Izagirre A, Martinez-Lage Alvarez P, Villanua J, Barkhof F, Sanz-Arigita E. Functional brain network centrality is related to APOE genotype in cognitively normal elderly. Brain and Behavior. e01080. PMID 30136422 DOI: 10.1002/brb3.1080  0.84
2018 Brownlee WJ, Miszkiel KA, Tur C, Barkhof F, Miller DH, Ciccarelli O. Inclusion of optic nerve involvement in dissemination in space criteria for multiple sclerosis. Neurology. PMID 30120132 DOI: 10.1212/WNL.0000000000006207  0.48
2018 Wolters EE, Golla SSV, Timmers T, Ossenkoppele R, van der Weijden CWJ, Scheltens P, Schwarte L, Schuit RC, Windhorst AD, Barkhof F, Yaqub M, Lammertsma AA, Boellaard R, van Berckel BNM. A novel partial volume correction method for accurate quantification of [F] flortaucipir in the hippocampus. Ejnmmi Research. 8: 79. PMID 30112620 DOI: 10.1186/s13550-018-0432-2  1
2018 Reus LM, Vijverberg EG, Tijms BM, Kate MT, Gossink F, Krudop WA, Campo MD, Teunissen CE, Barkhof F, van der Flier WM, Visser PJ, Dols A, Pijnenburg YA. Disease trajectories in behavioural variant frontotemporal dementia, primary psychiatric and other neurodegenerative disorders presenting with behavioural change. Journal of Psychiatric Research. 104: 183-191. PMID 30103065 DOI: 10.1016/j.jpsychires.2018.07.014  1
2018 Wijburg MT, Warnke C, Barkhof F, Uitdehaag BMJ, Killestein J, Wattjes MP. Performance of PML diagnostic criteria in natalizumab-associated PML: data from the Dutch-Belgian cohort. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 30100552 DOI: 10.1136/jnnp-2018-318261  0.84
2018 Slot RER, Verfaillie SCJ, Overbeek JM, Timmers T, Wesselman LMP, Teunissen CE, Dols A, Bouwman FH, Prins ND, Barkhof F, Lammertsma AA, Van Berckel BNM, Scheltens P, Sikkes SAM, Van der Flier WM. Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results. Alzheimer's Research & Therapy. 10: 76. PMID 30081935 DOI: 10.1186/s13195-018-0390-y  1
2018 Konijnenberg E, Carter SF, Ten Kate M, den Braber A, Tomassen J, Amadi C, Wesselman L, Nguyen HT, van de Kreeke JA, Yaqub M, Demuru M, Mulder SD, Hillebrand A, Bouwman FH, Teunissen CE, ... ... Barkhof F, et al. The EMIF-AD PreclinAD study: study design and baseline cohort overview. Alzheimer's Research & Therapy. 10: 75. PMID 30075734 DOI: 10.1186/s13195-018-0406-7  1
2018 de Wilde A, van Buchem MM, Otten RHJ, Bouwman F, Stephens A, Barkhof F, Scheltens P, van der Flier WM. Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic review. Alzheimer's Research & Therapy. 10: 72. PMID 30055660 DOI: 10.1186/s13195-018-0398-3  1
2018 Groot C, Tolboom N, Ikonomovic MD, Lammertsma AA, Boon BDC, Barkhof F, Scheltens P, Klunk WE, Rozemuller AJM, Ossenkoppele R, van Berckel BNM. Quantitative PET and Histology of Brain Biopsy Reveal Lack of Selective Pittsburgh Compound-B Binding to Intracerebral Amyloidoma. Journal of Alzheimer's Disease : Jad. PMID 30040724 DOI: 10.3233/JAD-180316  1
2018 Scheltens NME, van der Weijden K, Adriaanse SM, van Assema D, Oomen PP, Krudop WA, Lammertsma AA, Barkhof F, Koene T, Teunissen CE, Scheltens P, van der Flier WM, Pijnenburg YAL, Yaqub M, Ossenkoppele R, et al. Hypometabolism of the posterior cingulate cortex is not restricted to Alzheimer's disease. Neuroimage. Clinical. 19: 625-632. PMID 29984170 DOI: 10.1016/j.nicl.2018.05.024  1
2018 Amiri H, de Sitter A, Bendfeldt K, Battaglini M, Gandini Wheeler-Kingshott CAM, Calabrese M, Geurts JJG, Rocca MA, Sastre-Garriga J, Enzinger C, de Stefano N, Filippi M, Rovira Á, Barkhof F, Vrenken H, et al. Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI. Neuroimage. Clinical. 19: 466-475. PMID 29984155 DOI: 10.1016/j.nicl.2018.04.023  0.88
2018 Bos I, Vos S, Vandenberghe R, Scheltens P, Engelborghs S, Frisoni G, Molinuevo JL, Wallin A, Lleó A, Popp J, Martinez-Lage P, Baird A, Dobson R, Legido-Quigley C, Sleegers K, ... ... Barkhof F, et al. The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics. Alzheimer's Research & Therapy. 10: 64. PMID 29980228 DOI: 10.1186/s13195-018-0396-5  1
2018 Hagens MHJ, Burggraaff J, Kilsdonk ID, de Vos ML, Cawley N, Sbardella E, Andelova M, Amann M, Lieb JM, Pantano P, Lissenberg-Witte BI, Killestein J, Oreja-Guevara C, Ciccarelli O, Gasperini C, ... ... Barkhof F, et al. Three-Tesla MRI does not improve the diagnosis of multiple sclerosis: A multicenter study. Neurology. PMID 29925550 DOI: 10.1212/WNL.0000000000005825  0.84
2018 Tolonen A, Rhodius-Meester HFM, Bruun M, Koikkalainen J, Barkhof F, Lemstra AW, Koene T, Scheltens P, Teunissen CE, Tong T, Guerrero R, Schuh A, Ledig C, Baroni M, Rueckert D, et al. Data-Driven Differential Diagnosis of Dementia Using Multiclass Disease State Index Classifier. Frontiers in Aging Neuroscience. 10: 111. PMID 29922145 DOI: 10.3389/fnagi.2018.00111  1
2018 de Wilde A, van der Flier WM, Pelkmans W, Bouwman F, Verwer J, Groot C, van Buchem MM, Zwan M, Ossenkoppele R, Yaqub M, Kunneman M, Smets EMA, Barkhof F, Lammertsma AA, Stephens A, et al. Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort: The ABIDE Project. Jama Neurology. PMID 29889941 DOI: 10.1001/jamaneurol.2018.1346  1
2018 Leeuwis AE, Prins ND, Hooghiemstra AM, Benedictus MR, Scheltens P, Barkhof F, van der Flier WM. Microbleeds are associated with depressive symptoms in Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 112-120. PMID 29780860 DOI: 10.1016/j.dadm.2017.11.006  1
2018 Eijgelaar RS, Bruynzeel AME, Lagerwaard FJ, Müller DMJ, Teunissen FR, Barkhof F, van Herk M, De Witt Hamer PC, Witte MG. Earliest radiological progression in glioblastoma by multidisciplinary consensus review. Journal of Neuro-Oncology. PMID 29777418 DOI: 10.1007/s11060-018-2896-3  0.44
2018 Eshaghi A, Marinescu RV, Young AL, Firth NC, Prados F, Jorge Cardoso M, Tur C, De Angelis F, Cawley N, Brownlee WJ, De Stefano N, Laura Stromillo M, Battaglini M, Ruggieri S, Gasperini C, ... ... Barkhof F, et al. Progression of regional grey matter atrophy in multiple sclerosis. Brain : a Journal of Neurology. PMID 29741648 DOI: 10.1093/brain/awy088  0.88
2018 van Duinkerken E, Steenwijk MD, Klein M, Barkhof F, Mograbi DC, Diamant M, Snoek FJ, Ijzerman RG. Accelerated executive functions decline and gray matter structural changes in middle-aged type 1 diabetes patients with proliferative retinopathy. Journal of Diabetes. PMID 29665283 DOI: 10.1111/1753-0407.12773  0.84
2018 Bernardes G, IJzerman RG, Ten Kulve JS, Barkhof F, Diamant M, Veltman DJ, Landeira-Fernandez J, van Bloemendaal L, van Duinkerken E. Cortical and subcortical gray matter structural alterations in normoglycemic obese and type 2 diabetes patients: relationship with adiposity, glucose, and insulin. Metabolic Brain Disease. PMID 29654499 DOI: 10.1007/s11011-018-0223-5  0.64
2018 Bouts MJRJ, Möller C, Hafkemeijer A, van Swieten JC, Dopper E, van der Flier WM, Vrenken H, Wink AM, Pijnenburg YAL, Scheltens P, Barkhof F, Schouten TM, de Vos F, Feis RA, van der Grond J, et al. Single Subject Classification of Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Using Anatomical, Diffusion Tensor, and Resting-State Functional Magnetic Resonance Imaging. Journal of Alzheimer's Disease : Jad. PMID 29614652 DOI: 10.3233/JAD-170893  1
2018 Verfaillie SCJ, Slot RER, Dicks E, Prins ND, Overbeek JM, Teunissen CE, Scheltens P, Barkhof F, van der Flier WM, Tijms BM. A more randomly organized grey matter network is associated with deteriorating language and global cognition in individuals with subjective cognitive decline. Human Brain Mapping. PMID 29602212 DOI: 10.1002/hbm.24065  1
2018 Ten Kate M, Visser PJ, Bakardjian H, Barkhof F, Sikkes SAM, van der Flier WM, Scheltens P, Hampel H, Habert MO, Dubois B, Tijms BM. Gray Matter Network Disruptions and Regional Amyloid Beta in Cognitively Normal Adults. Frontiers in Aging Neuroscience. 10: 67. PMID 29599717 DOI: 10.3389/fnagi.2018.00067  1
2018 Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, DeLuca GC, Kappos L, Yousry T, Fazekas F, Frederiksen J, et al. The current role of MRI in differentiating multiple sclerosis from its imaging mimics. Nature Reviews. Neurology. 14: 213. PMID 29582852 DOI: 10.1038/nrneurol.2018.39  0.48
2018 Leijenaar JF, Groeneveld GJ, van der Flier WM, Scheltens P, Klaassen ES, Weinstein HC, Biessels GJ, Barkhof F, Prins ND. Symptomatic Treatment of Vascular Cognitive Impairment (STREAM-VCI): Protocol for a Cross-Over Trial. Jmir Research Protocols. 7: e80. PMID 29559423 DOI: 10.2196/resprot.9192  1
2018 Haller S, Vernooij MW, Kuijer JPA, Larsson EM, Jäger HR, Barkhof F. Cerebral Microbleeds: Imaging and Clinical Significance. Radiology. 287: 11-28. PMID 29558307 DOI: 10.1148/radiol.2018170803  0.88
2018 Wijburg MT, Kleerekooper I, Lissenberg-Witte BI, de Vos M, Warnke C, Uitdehaag BMJ, Barkhof F, Killestein J, Wattjes MP. Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis. Jama Neurology. PMID 29532061 DOI: 10.1001/jamaneurol.2018.0094  0.84
2018 Buck D, Andlauer TF, Igl W, Wicklein EM, Mühlau M, Weber F, Köchert K, Pohl C, Arnason B, Comi G, Cook S, Filippi M, Hartung HP, Jeffery D, Kappos L, ... Barkhof F, et al. Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518763089. PMID 29521573 DOI: 10.1177/1352458518763089  0.48
2018 Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, DeLuca GC, Kappos L, Yousry T, Fazekas F, Frederiksen J, et al. The current role of MRI in differentiating multiple sclerosis from its imaging mimics. Nature Reviews. Neurology. PMID 29521337 DOI: 10.1038/nrneurol.2018.14  0.48
2018 Cortese R, Magnollay L, Tur C, Abdel-Aziz K, Jacob A, De Angelis F, Yiannakas MC, Prados F, Ourselin S, Yousry TA, Barkhof F, Ciccarelli O. Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD. Neurology. PMID 29514948 DOI: 10.1212/WNL.0000000000005256  0.32
2018 Ten Kate M, Sudre CH, den Braber A, Konijnenberg E, Nivard MG, Cardoso MJ, Scheltens P, Ourselin S, Boomsma DI, Barkhof F, Visser PJ. White matter hyperintensities and vascular risk factors in monozygotic twins. Neurobiology of Aging. 66: 40-48. PMID 29505954 DOI: 10.1016/j.neurobiolaging.2018.02.002  1
2018 Rhodius-Meester HFM, Liedes H, Koene T, Lemstra AW, Teunissen CE, Barkhof F, Scheltens P, van Gils M, Lötjönen J, van der Flier WM. Disease-related determinants are associated with mortality in dementia due to Alzheimer's disease. Alzheimer's Research & Therapy. 10: 23. PMID 29458426 DOI: 10.1186/s13195-018-0348-0  1
2018 Hendriks EJ, Habets EJJ, Taphoorn MJB, Douw L, Zwinderman AH, Vandertop WP, Barkhof F, Klein M, De Witt Hamer PC. Linking late cognitive outcome with glioma surgery location using resection cavity maps. Human Brain Mapping. PMID 29380489 DOI: 10.1002/hbm.23986  0.84
2018 Eshaghi A, Prados F, Brownlee W, Altmann DR, Tur C, Cardoso MJ, De Angelis F, van de Pavert SH, Cawley N, De Stefano N, Stromillo ML, Battaglini M, Ruggieri S, Gasperini C, Filippi M, ... ... Barkhof F, et al. Deep grey matter volume loss drives disability worsening in multiple sclerosis. Annals of Neurology. PMID 29331092 DOI: 10.1002/ana.25145  0.8
2018 Hagens MH, Burggraaff J, Kilsdonk ID, Ruggieri S, Collorone S, Cortese R, Cawley N, Sbardella E, Andelova M, Amann M, Lieb JM, Pantano P, Lissenberg-Witte BI, Killestein J, Oreja-Guevara C, ... ... Barkhof F, et al. Impact of 3 Tesla MRI on interobserver agreement in clinically isolated syndrome: A MAGNIMS multicentre study. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517751647. PMID 29327668 DOI: 10.1177/1352458517751647  0.84
2018 Tur C, Moccia M, Barkhof F, Chataway J, Sastre-Garriga J, Thompson AJ, Ciccarelli O. Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting. Nature Reviews. Neurology. PMID 29326424 DOI: 10.1038/nrneurol.2017.171  0.4
2018 Rimkus CM, Schoonheim MM, Steenwijk MD, Vrenken H, Eijlers AJ, Killestein J, Wattjes MP, Leite CC, Barkhof F, Tijms BM. Gray matter networks and cognitive impairment in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517751650. PMID 29320933 DOI: 10.1177/1352458517751650  0.88
2017 Filippi M, Preziosa P, Meani A, Ciccarelli O, Mesaros S, Rovira A, Frederiksen J, Enzinger C, Barkhof F, Gasperini C, Brownlee W, Drulovic J, Montalban X, Cramer SP, Pichler A, et al. Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study. The Lancet. Neurology. PMID 29275979 DOI: 10.1016/S1474-4422(17)30469-6  0.76
2017 Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet. Neurology. PMID 29275977 DOI: 10.1016/S1474-4422(17)30470-2  0.76
2017 Groot C, van Loenhoud AC, Barkhof F, van Berckel BNM, Koene T, Teunissen CC, Scheltens P, van der Flier WM, Ossenkoppele R. Differential effects of cognitive reserve and brain reserve on cognition in Alzheimer disease. Neurology. PMID 29237798 DOI: 10.1212/WNL.0000000000004802  1
2017 Leijenaar JF, van Maurik IS, Kuijer JPA, van der Flier WM, Scheltens P, Barkhof F, Prins ND. Lower cerebral blood flow in subjects with Alzheimer's dementia, mild cognitive impairment, and subjective cognitive decline using two-dimensional phase-contrast magnetic resonance imaging. Alzheimer's & Dementia (Amsterdam, Netherlands). 9: 76-83. PMID 29234724 DOI: 10.1016/j.dadm.2017.10.001  1
2017 Ostrowitzki S, Lasser RA, Dorflinger E, Scheltens P, Barkhof F, Nikolcheva T, Ashford E, Retout S, Hofmann C, Delmar P, Klein G, Andjelkovic M, Dubois B, Boada M, Blennow K, et al. A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease. Alzheimer's Research & Therapy. 9: 95. PMID 29221491 DOI: 10.1186/s13195-017-0318-y  1
2017 Wattjes MP, Wijburg MT, Eijk JV, Frequin S, Uitdehaag BMJ, Barkhof F, Warnke C, Killestein J. Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 29142146 DOI: 10.1136/jnnp-2017-316886  0.84
2017 Sudre CH, Anson BG, Davagnanamd I, Schmitt A, Mendelson AF, Prados F, Smith L, Atkinson D, Hughes AD, Chaturvedi N, Cardoso MJ, Barkhof F, Jaeger HR, Ourselin S. Bullseye's representation of cerebral white matter hyperintensities. Journal of Neuroradiology. Journal De Neuroradiologie. PMID 29132940 DOI: 10.1016/j.neurad.2017.10.001  0.32
2017 Dicks E, Tijms BM, Ten Kate M, Gouw AA, Benedictus MR, Teunissen CE, Barkhof F, Scheltens P, van der Flier WM. Gray matter network measures are associated with cognitive decline in mild cognitive impairment. Neurobiology of Aging. 61: 198-206. PMID 29111486 DOI: 10.1016/j.neurobiolaging.2017.09.029  1
2017 Dekker I, Sombekke MH, Witte BI, Geurts JJ, Barkhof F, Uitdehaag BM, Killestein J, Wattjes MP. Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517736147. PMID 29106327 DOI: 10.1177/1352458517736147  0.84
2017 Leeuwis AE, Hooghiemstra AM, Amier R, Ferro DA, Franken L, Nijveldt R, Kuijer JPA, Bronzwaer AGT, van Lieshout JJ, Rietberg MB, Veerbeek JM, Huijsmans RJ, Backx FJG, Teunissen CE, Bron EE, ... Barkhof F, et al. Design of the ExCersion-VCI study: The effect of aerobic exercise on cerebral perfusion in patients with vascular cognitive impairment. Alzheimer's & Dementia (New York, N. Y.). 3: 157-165. PMID 29067325 DOI: 10.1016/j.trci.2017.02.002  1
2017 van Maurik IS, Zwan MD, Tijms BM, Bouwman FH, Teunissen CE, Scheltens P, Wattjes MP, Barkhof F, Berkhof J, van der Flier WM. Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project. Jama Neurology. PMID 29049480 DOI: 10.1001/jamaneurol.2017.2712  1
2017 Tijms BM, Ten Kate M, Gouw AA, Borta A, Verfaillie S, Teunissen CE, Scheltens P, Barkhof F, van der Flier WM. Gray matter networks and clinical progression in subjects with predementia Alzheimer's disease. Neurobiology of Aging. 61: 75-81. PMID 29040871 DOI: 10.1016/j.neurobiolaging.2017.09.011  1
2017 Verfaillie SCJ, Slot RE, Tijms BM, Bouwman F, Benedictus MR, Overbeek JM, Koene T, Vrenken H, Scheltens P, Barkhof F, van der Flier WM. Thinner cortex in patients with subjective cognitive decline is associated with steeper decline of memory. Neurobiology of Aging. PMID 29029762 DOI: 10.1016/j.neurobiolaging.2017.09.009  1
2017 Ten Kulve JS, Veltman DJ, Gerdes VEA, van Bloemendaal L, Barkhof F, Deacon CF, Holst JJ, Drent ML, Diamant M, IJzerman RG. Elevated Postoperative Endogenous GLP-1 Levels Mediate Effects of Roux-en-Y Gastric Bypass on Neural Responsivity to Food Cues. Diabetes Care. PMID 29025878 DOI: 10.2337/dc16-2113  0.64
2017 Martens RM, Bechten A, Ingala S, van Schijndel RA, Machado VB, de Jong MC, Sanchez E, Purcell D, Arrighi MH, Brashear RH, Wattjes MP, Barkhof F. The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer's patients: An interobserver study. European Radiology. PMID 28956123 DOI: 10.1007/s00330-017-5022-6  0.84
2017 de Sitter A, Steenwijk MD, Ruet A, Versteeg A, Liu Y, van Schijndel RA, Pouwels PJW, Kilsdonk ID, Cover KS, van Dijk BW, Ropele S, Rocca MA, Yiannakas M, Wattjes MP, Damangir S, ... ... Barkhof F, et al. Performance of five research-domain automated WM lesion segmentation methods in a multi-center MS study. Neuroimage. PMID 28899746 DOI: 10.1016/j.neuroimage.2017.09.011  0.84
2017 Ten Kate M, Barkhof F, Visser PJ, Teunissen CE, Scheltens P, van der Flier WM, Tijms BM. Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment. Alzheimer's Research & Therapy. 9: 73. PMID 28899429 DOI: 10.1186/s13195-017-0299-x  1
2017 Steenwijk MD, Amiri H, Schoonheim MM, de Sitter A, Barkhof F, Pouwels PJW, Vrenken H. Agreement of MSmetrix with established methods for measuring cross-sectional and longitudinal brain atrophy. Neuroimage. Clinical. 15: 843-853. PMID 28794970 DOI: 10.1016/j.nicl.2017.06.034  0.8
2017 Frisoni GB, Boccardi M, Barkhof F, Blennow K, Cappa S, Chiotis K, Démonet JF, Garibotto V, Giannakopoulos P, Gietl A, Hansson O, Herholz K, Jack CR, Nobili F, Nordberg A, et al. Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers. The Lancet. Neurology. 16: 661-676. PMID 28721928 DOI: 10.1016/S1474-4422(17)30159-X  1
2017 Tong T, Ledig C, Guerrero R, Schuh A, Koikkalainen J, Tolonen A, Rhodius H, Barkhof F, Tijms B, Lemstra AW, Soininen H, Remes AM, Waldemar G, Hasselbalch S, Mecocci P, et al. Five-class differential diagnostics of neurodegenerative diseases using random undersampling boosting. Neuroimage. Clinical. 15: 613-624. PMID 28664032 DOI: 10.1016/j.nicl.2017.06.012  0.64
2017 van Loenhoud AC, Wink AM, Groot C, Verfaillie SCJ, Twisk J, Barkhof F, van Berckel B, Scheltens P, van der Flier WM, Ossenkoppele R. A neuroimaging approach to capture cognitive reserve: Application to Alzheimer's disease. Human Brain Mapping. PMID 28631336 DOI: 10.1002/hbm.23695  1
2017 Hoefnagels FWA, de Witt Hamer PC, Pouwels PJW, Barkhof F, Vandertop WP. Impact of gradient number and voxel size on DTI tractography for resective brain surgery. World Neurosurgery. PMID 28624562 DOI: 10.1016/j.wneu.2017.06.050  0.8
2017 Doornweerd S, De Geus EJ, Barkhof F, Van Bloemendaal L, Boomsma DI, Van Dongen J, Drent ML, Willemsen G, Veltman DJ, IJzerman RG. Brain reward responses to food stimuli among female monozygotic twins discordant for BMI. Brain Imaging and Behavior. PMID 28597337 DOI: 10.1007/s11682-017-9711-1  0.64
2017 Cavedo E, Lista S, Rojkova K, Andrea Chiesa P, Houot M, Brueggen K, Blautzik J, Bokde ALW, Dubois B, Barkhof F, Pouwels PJW, Teipel S, Hampel H. Disrupted white matter structural networks in healthy older adults APOE ε4 carriers - An International Multicenter DTI Study. Neuroscience. PMID 28596117 DOI: 10.1016/j.neuroscience.2017.05.048  0.8
2017 Vrij-van den Bos S, Hol JA, La Piana R, Harting I, Vanderver A, Barkhof F, Cayami F, van Wieringen WN, Pouwels PJW, van der Knaap MS, Bernard G, Wolf NI. 4H Leukodystrophy: A Brain Magnetic Resonance Imaging Scoring System. Neuropediatrics. 48: 152-160. PMID 28561206 DOI: 10.1055/s-0037-1599141  0.8
2017 Rhodius-Meester HFM, Benedictus MR, Wattjes MP, Barkhof F, Scheltens P, Muller M, van der Flier WM. MRI Visual Ratings of Brain Atrophy and White Matter Hyperintensities across the Spectrum of Cognitive Decline Are Differently Affected by Age and Diagnosis. Frontiers in Aging Neuroscience. 9: 117. PMID 28536518 DOI: 10.3389/fnagi.2017.00117  1
2017 Harper L, Bouwman F, Burton EJ, Barkhof F, Scheltens P, O'Brien JT, Fox NC, Ridgway GR, Schott JM. Patterns of atrophy in pathologically confirmed dementias: a voxelwise analysis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28473626 DOI: 10.1136/jnnp-2016-314978  1
2017 Meijer KA, Eijlers AJC, Douw L, Uitdehaag BMJ, Barkhof F, Geurts JJG, Schoonheim MM. Increased connectivity of hub networks and cognitive impairment in multiple sclerosis. Neurology. PMID 28468841 DOI: 10.1212/WNL.0000000000003982  0.88
2017 Hagens MH, Killestein J, Yaqub MM, van Dongen GA, Lammertsma AA, Barkhof F, van Berckel BN. Cerebral rituximab uptake in multiple sclerosis: A (89)Zr-immunoPET pilot study. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517704507. PMID 28443358 DOI: 10.1177/1352458517704507  0.68
2017 van Duinkerken E, Schoonheim MM, IJzerman RG, Moll AC, Landeira-Fernandez J, Klein M, Diamant M, Snoek FJ, Barkhof F, Wink AM. Altered eigenvector centrality is related to local resting-state network functional connectivity in patients with longstanding type 1 diabetes mellitus. Human Brain Mapping. PMID 28429383 DOI: 10.1002/hbm.23617  0.84
2017 Boomsma JMF, Exalto LG, Barkhof F, van den Berg E, de Bresser J, Heinen R, Koek HL, Prins ND, Scheltens P, Weinstein HC, van der Flier WM, Biessels GJ. Vascular Cognitive Impairment in a Memory Clinic Population: Rationale and Design of the "Utrecht-Amsterdam Clinical Features and Prognosis in Vascular Cognitive Impairment" (TRACE-VCI) Study. Jmir Research Protocols. 6: e60. PMID 28428166 DOI: 10.2196/resprot.6864  1
2017 Scheltens NME, Tijms BM, Koene T, Barkhof F, Teunissen CE, Wolfsgruber S, Wagner M, Kornhuber J, Peters O, Cohn-Sheehy BI, Rabinovici GD, Miller BL, Kramer JH, Scheltens P, van der Flier WM, et al. Cognitive subtypes of probable Alzheimer's disease robustly identified in four cohorts. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28427934 DOI: 10.1016/j.jalz.2017.03.002  1
2017 Klauser AM, Wiebenga OT, Eijlers AJ, Schoonheim MM, Uitdehaag BM, Barkhof F, Pouwels PJ, Geurts JJ. Metabolites predict lesion formation and severity in relapsing-remitting multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517702534. PMID 28406063 DOI: 10.1177/1352458517702534  0.84
2017 Fällmar D, Haller S, Lilja J, Danfors T, Kilander L, Tolboom N, Egger K, Kellner E, Croon PM, Verfaillie SC, van Berckel BN, Ossenkoppele R, Barkhof F, Larsson EM. Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PET. European Radiology. PMID 28374078 DOI: 10.1007/s00330-017-4784-1  0.72
2017 Ten Kate M, Barkhof F, Boccardi M, Visser PJ, Jack CR, Lovblad KO, Frisoni GB, Scheltens P. Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. Neurobiology of Aging. 52: 167-182.e1. PMID 28317647 DOI: 10.1016/j.neurobiolaging.2016.05.024  1
2017 Ketter N, Brashear HR, Bogert J, Di J, Miaux Y, Gass A, Purcell DD, Barkhof F, Arrighi HM. Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients. Journal of Alzheimer's Disease : Jad. PMID 28269765 DOI: 10.3233/JAD-160216  0.6
2017 Vrij-van den Bos S, Hol JA, La Piana R, Harting I, Vanderver A, Barkhof F, Cayami F, van Wieringen WN, Pouwels PJ, van der Knaap MS, Bernard G, Wolf NI. 4H Leukodystrophy: A Brain Magnetic Resonance Imaging Scoring System. Neuropediatrics. PMID 28249300 DOI: 10.1055/s-0037-1599141  0.8
2017 de Wilde A, van Maurik IS, Kunneman M, Bouwman F, Zwan M, Willemse EA, Biessels GJ, Minkman M, Pel R, Schoonenboom NS, Smets EM, Wattjes MP, Barkhof F, Stephens A, van Lier EJ, et al. Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design. Alzheimer's & Dementia (Amsterdam, Netherlands). 6: 143-151. PMID 28239639 DOI: 10.1016/j.dadm.2017.01.003  1
2017 Sudre CH, Cardoso MJ, Frost C, Barnes J, Barkhof F, Fox N, Ourselin S. APOE ε4 status is associated with white matter hyperintensities volume accumulation rate independent of AD diagnosis. Neurobiology of Aging. 53: 67-75. PMID 28235680 DOI: 10.1016/j.neurobiolaging.2017.01.014  0.6
2017 Bartel F, Vrenken H, Bijma F, Barkhof F, van Herk M, de Munck JC. Regional analysis of volumes and reproducibilities of automatic and manual hippocampal segmentations. Plos One. 12: e0166785. PMID 28182655 DOI: 10.1371/journal.pone.0166785  0.8
2017 Eijlers AJ, Meijer KA, Wassenaar TM, Steenwijk MD, Uitdehaag BM, Barkhof F, Wink AM, Geurts JJ, Schoonheim MM. Increased default-mode network centrality in cognitively impaired multiple sclerosis patients. Neurology. PMID 28179464 DOI: 10.1212/WNL.0000000000003689  0.8
2017 Derks J, Dirkson AR, de Witt Hamer PC, van Geest Q, Hulst HE, Barkhof F, Pouwels PJ, Geurts JJ, Reijneveld JC, Douw L. Connectomic profile and clinical phenotype in newly diagnosed glioma patients. Neuroimage. Clinical. 14: 87-96. PMID 28154795 DOI: 10.1016/j.nicl.2017.01.007  0.8
2017 van Zanten SE, Baugh J, Chaney B, De Jongh D, Aliaga ES, Barkhof F, Noltes J, De Wolf R, Van Dijk J, Cannarozzo A, Damen-Korbijn CM, Lieverst JA, Colditz N, Hoffmann M, Warmuth-Metz M, et al. Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease. Journal of Neuro-Oncology. PMID 28110411 DOI: 10.1007/s11060-016-2363-y  0.4
2017 Bechten A, Wattjes MP, Purcell DD, Aliaga ES, Daams M, Brashear HR, Arrighi HM, Barkhof F. Validation of an MRI Rating Scale for Amyloid-Related Imaging Abnormalities. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 28102639 DOI: 10.1111/jon.12422  0.84
2016 Rimkus CM, Steenwijk MD, Barkhof F. Causes, effects and connectivity changes in MS-related cognitive decline. Dementia & Neuropsychologia. 10: 2-11. PMID 29213424 DOI: 10.1590/S1980-57642016DN10100002  0.8
2016 Scheltens NME, Kuyper IS, Boellaard R, Barkhof F, Teunissen CE, Broersen LM, Lansbergen MM, van der Flier WM, van Berckel BNM, Scheltens P. Design of the NL-ENIGMA study: Exploring the effect of Souvenaid on cerebral glucose metabolism in early Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 2: 233-240. PMID 29067310 DOI: 10.1016/j.trci.2016.07.004  1
2016 Verfaillie SC, Tijms B, Versteeg A, Benedictus MR, Bouwman FH, Scheltens P, Barkhof F, Vrenken H, van der Flier WM. Thinner temporal and parietal cortex is related to incident clinical progression to dementia in patients with subjective cognitive decline. Alzheimer's & Dementia (Amsterdam, Netherlands). 5: 43-52. PMID 28054027 DOI: 10.1016/j.dadm.2016.10.007  1
2016 Comi G, De Stefano N, Freedman MS, Barkhof F, Uitdehaag BM, de Vos M, Marhardt K, Chen L, Issard D, Kappos L. Subcutaneous interferon β-1a in the treatment of clinically isolated syndromes: 3-year and 5-year results of the phase III dosing frequency-blind multicentre REFLEXION study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28039317 DOI: 10.1136/jnnp-2016-314843  0.68
2016 Jokinen H, Melkas S, Madureira S, Verdelho A, Ferro JM, Fazekas F, Schmidt R, Scheltens P, Barkhof F, Wardlaw JM, Inzitari D, Pantoni L, Erkinjuntti T. Cognitive reserve moderates long-term cognitive and functional outcome in cerebral small vessel disease. Journal of Neurology, Neurosurgery, and Psychiatry. 87: 1296-1302. PMID 27951523 DOI: 10.1136/jnnp-2016-313914  1
2016 Louwersheimer E, Cohn-Hokke PE, Pijnenburg YA, Weiss MM, Sistermans EA, Rozemuller AJ, Hulsman M, van Swieten JC, van Duijn CM, Barkhof F, Koene T, Scheltens P, Van der Flier WM, Holstege H. Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity. Journal of Alzheimer's Disease : Jad. PMID 27911290 DOI: 10.3233/JAD-160091  1
2016 Dols A, Bouckaert F, Sienaert P, Rhebergen D, Vansteelandt K, Ten Kate M, de Winter FL, Comijs HC, Emsell L, Oudega ML, van Exel E, Schouws S, Obbels J, Wattjes M, Barkhof F, et al. Early- and Late-Onset Depression in Late Life: A Prospective Study on Clinical and Structural Brain Characteristics and Response to Electroconvulsive Therapy. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 27771245 DOI: 10.1016/j.jagp.2016.09.005  0.84
2016 Leeuwis AE, Benedictus MR, Kuijer JP, Binnewijzend MA, Hooghiemstra AM, Verfaillie SC, Koene T, Scheltens P, Barkhof F, Prins ND, van der Flier WM. Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27693109 DOI: 10.1016/j.jalz.2016.08.013  1
2016 Freeze WM, Jacobs HI, Gronenschild EH, Jansen JF, Burgmans S, Aalten P, Clerx L, Vos SJ, van Buchem MA, Barkhof F, van der Flier WM, Verbeek MM, Rikkert MO, Backes WH, Verhey FR, et al. White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-β. Journal of Alzheimer's Disease : Jad. PMID 27662299 DOI: 10.3233/JAD-160474  1
2016 Hafkemeijer A, Möller C, Dopper EG, Jiskoot LC, van den Berg-Huysmans AA, van Swieten JC, van der Flier WM, Vrenken H, Pijnenburg YA, Barkhof F, Scheltens P, van der Grond J, Rombouts SA. A Longitudinal Study on Resting State Functional Connectivity in Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 27662284 DOI: 10.3233/JAD-150695  1
2016 Wijburg MT, Witte BI, Vennegoor A, Roosendaal SD, Sanchez E, Liu Y, Martins Jarnalo CO, Uitdehaag BM, Barkhof F, Killestein J, Wattjes MP. MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 27530808 DOI: 10.1136/jnnp-2016-313772  0.88
2016 Kappos L, Edan G, Freedman MS, Montalbán X, Hartung HP, Hemmer B, Fox EJ, Barkhof F, Schippling S, Schulze A, Pleimes D, Pohl C, Sandbrink R, Suarez G, Wicklein EM, et al. The 11-year long-term follow-up study from the randomized BENEFIT CIS trial. Neurology. PMID 27511182 DOI: 10.1212/WNL.0000000000003078  0.32
2016 Verburg N, Pouwels PJ, Boellaard R, Barkhof F, Hoekstra OS, Reijneveld JC, Vandertop WP, Wesseling P, de Witt Hamer PC. Accurate Delineation of Glioma Infiltration by Advanced PET/MR Neuro-Imaging (FRONTIER Study): A Diagnostic Study Protocol. Neurosurgery. PMID 27479710 DOI: 10.1227/NEU.0000000000001355  0.8
2016 Steenweg ME, Wolf NI, van Wieringen WN, Barkhof F, van der Knaap MS, Pouwels PJ. Quantitative MRI in hypomyelinating disorders: Correlation with motor handicap. Neurology. PMID 27440150 DOI: 10.1212/WNL.0000000000003000  0.8
2016 Sormani MP, Kappos L, Radue EW, Cohen J, Barkhof F, Sprenger T, Piani Meier D, Häring D, Tomic D, De Stefano N. Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27411701 DOI: 10.1177/1352458516659550  0.52
2016 Shu N, Duan Y, Xia M, Schoonheim MM, Huang J, Ren Z, Sun Z, Ye J, Dong H, Shi FD, Barkhof F, Li K, Liu Y. Disrupted topological organization of structural and functional brain connectomes in clinically isolated syndrome and multiple sclerosis. Scientific Reports. 6: 29383. PMID 27403924 DOI: 10.1038/srep29383  0.88
2016 Collij LE, Heeman F, Kuijer JP, Ossenkoppele R, Benedictus MR, Möller C, Verfaillie SC, Sanz-Arigita EJ, van Berckel BN, van der Flier WM, Scheltens P, Barkhof F, Wink AM. Application of Machine Learning to Arterial Spin Labeling in Mild Cognitive Impairment and Alzheimer Disease. Radiology. 152703. PMID 27383395 DOI: 10.1148/radiol.2016152703  1
2016 Vijverberg EG, Wattjes MP, Dols A, Krudop WA, Möller C, Peters A, Kerssens CJ, Gossink F, Prins ND, Stek ML, Scheltens P, van Berckel BN, Barkhof F, Pijnenburg YA. Diagnostic Accuracy of MRI and Additional [18F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes. Journal of Alzheimer's Disease : Jad. PMID 27372646 DOI: 10.3233/JAD-160285  0.88
2016 Chételat G, Ossenkoppele R, Villemagne VL, Perrotin A, Landeau B, Mézenge F, Jagust WJ, Dore V, Miller BL, Egret S, Seeley WW, van der Flier WM, La Joie R, Ames D, van Berckel BN, ... ... Barkhof F, et al. Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease. Brain : a Journal of Neurology. PMID 27357349 DOI: 10.1093/brain/aww159  1
2016 Benedictus MR, Leeuwis AE, Binnewijzend MA, Kuijer JP, Scheltens P, Barkhof F, van der Flier WM, Prins ND. Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer's disease. European Radiology. PMID 27334014 DOI: 10.1007/s00330-016-4450-z  0.88
2016 Cohn-Hokke PE, Holstege H, Weiss MM, van der Flier WM, Barkhof F, Sistermans EA, Pijnenburg YA, van Swieten JC, Meijers-Heijboer H, Scheltens P. A novel CCM2 variant in a family with non-progressive cognitive complaints and cerebral microbleeds. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. PMID 27277535 DOI: 10.1002/ajmg.b.32468  1
2016 Cover KS, van Schijndel RA, Versteeg A, Leung KK, Mulder ER, Jong RA, Visser PJ, Redolfi A, Revillard J, Grenier B, Manset D, Damangir S, Bosco P, Vrenken H, van Dijk BW, ... ... Barkhof F, et al. Reproducibility of hippocampal atrophy rates measured with manual, FreeSurfer, AdaBoost, FSL/FIRST and the MAPS-HBSI methods in Alzheimer's disease. Psychiatry Research. 252: 26-35. PMID 27179313 DOI: 10.1016/j.pscychresns.2016.04.006  0.88
2016 Vijverberg EG, Dols A, Krudop WA, Peters A, Kerssens CJ, van Berckel BN, Wattjes MP, Barkhof F, Gossink F, Prins ND, Stek ML, Scheltens P, Pijnenburg YA. Diagnostic Accuracy of the Frontotemporal Dementia Consensus Criteria in the Late-Onset Frontal Lobe Syndrome. Dementia and Geriatric Cognitive Disorders. 41: 210-9. PMID 27160162 DOI: 10.1159/000444849  0.88
2016 van Duinkerken E, Ryan CM, Schoonheim MM, Barkhof F, Klein M, Moll AC, Diamant M, IJzerman RG, Snoek FJ. Subgenual Cingulate Cortex Functional Connectivity in Relation to Depressive Symptoms and Cognitive Functioning in Type 1 Diabetes Mellitus Patients. Psychosomatic Medicine. PMID 27136504 DOI: 10.1097/PSY.0000000000000335  0.88
2016 Koikkalainen J, Rhodius-Meester H, Tolonen A, Barkhof F, Tijms B, Lemstra AW, Tong T, Guerrero R, Schuh A, Ledig C, Rueckert D, Soininen H, Remes AM, Waldemar G, Hasselbalch S, et al. Differential diagnosis of neurodegenerative diseases using structural MRI data. Neuroimage. Clinical. 11: 435-49. PMID 27104138 DOI: 10.1016/j.nicl.2016.02.019  0.84
2016 Hagens M, van Berckel B, Barkhof F. Novel MRI and PET markers of neuroinflammation in multiple sclerosis. Current Opinion in Neurology. PMID 27058220 DOI: 10.1097/WCO.0000000000000326  0.52
2016 Brueggen K, Grothe MJ, Dyrba M, Fellgiebel A, Fischer F, Filippi M, Agosta F, Nestor P, Meisenzahl E, Blautzik J, Frölich L, Hausner L, Bokde AL, Frisoni G, Pievani M, ... ... Barkhof F, et al. The European DTI Study on Dementia - A multicenter DTI and MRI study on Alzheimer's disease and Mild Cognitive Impairment. Neuroimage. PMID 27046114 DOI: 10.1016/j.neuroimage.2016.03.067  0.8
2016 Marchitelli R, Minati L, Marizzoni M, Bosch B, Bartrés-Faz D, Müller BW, Wiltfang J, Fiedler U, Roccatagliata L, Picco A, Nobili F, Blin O, Bombois S, Lopes R, Bordet R, ... ... Barkhof F, et al. Test-retest reliability of the default mode network in a multi-centric fMRI study of healthy elderly: Effects of data-driven physiological noise correction techniques. Human Brain Mapping. PMID 26990928 DOI: 10.1002/hbm.23157  0.84
2016 Wiebenga OT, Schoonheim MM, Hulst HE, Nagtegaal GJ, Strijbis EM, Steenwijk MD, Polman CH, Pouwels PJ, Barkhof F, Geurts JJ. White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis. Ajnr. American Journal of Neuroradiology. PMID 26965463 DOI: 10.3174/ajnr.A4690  0.84
2016 Kilsdonk ID, Jonkman LE, Klaver R, van Veluw SJ, Zwanenburg JJ, Kuijer JP, Pouwels PJ, Twisk JW, Wattjes MP, Luijten PR, Barkhof F, Geurts JJ. Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study. Brain : a Journal of Neurology. PMID 26956422 DOI: 10.1093/brain/aww037  0.84
2016 Popescu V, Klaver R, Versteeg A, Voorn P, Twisk JW, Barkhof F, Geurts JJ, Vrenken H. Postmortem validation of MRI cortical volume measurements in MS. Human Brain Mapping. PMID 26945922 DOI: 10.1002/hbm.23168  0.88
2016 Harper L, Fumagalli GG, Barkhof F, Scheltens P, O'Brien JT, Bouwman F, Burton EJ, Rohrer JD, Fox NC, Ridgway GR, Schott JM. MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases. Brain : a Journal of Neurology. PMID 26936938 DOI: 10.1093/brain/aww005  0.88
2016 Preziosa P, Rocca MA, Pagani E, Stromillo ML, Enzinger C, Gallo A, Hulst HE, Atzori M, Pareto D, Riccitelli GC, Copetti M, De Stefano N, Fazekas F, Bisecco A, Barkhof F, et al. Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study. Human Brain Mapping. PMID 26833969 DOI: 10.1002/hbm.23125  1
2016 Möller C, Hafkemeijer A, Pijnenburg YA, Rombouts SA, van der Grond J, Dopper E, van Swieten J, Versteeg A, Steenwijk MD, Barkhof F, Scheltens P, Vrenken H, van der Flier WM. Different patterns of cortical gray matter loss over time in behavioral variant frontotemporal dementia and Alzheimer's disease. Neurobiology of Aging. 38: 21-31. PMID 26827640 DOI: 10.1016/j.neurobiolaging.2015.10.020  1
2016 Ten Kate M, Sanz-Arigita EJ, Tijms BM, Wink AM, Clerigue M, Garcia-Sebastian M, Izagirre A, Ecay-Torres M, Estanga A, Villanua J, Vrenken H, Visser PJ, Martinez-Lage P, Barkhof F. Impact of APOE-ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults. Neurobiology of Aging. 38: 14-20. PMID 26827639 DOI: 10.1016/j.neurobiolaging.2015.10.018  0.88
2016 Filippi M, Rocca MA, Ciccarelli O, De Stefano N, Evangelou N, Kappos L, Rovira A, Sastre-Garriga J, Tintorè M, Frederiksen JL, Gasperini C, Palace J, Reich DS, Banwell B, Montalban X, ... Barkhof F, et al. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. The Lancet. Neurology. PMID 26822746 DOI: 10.1016/S1474-4422(15)00393-2  0.88
2016 van Bloemendaal L, Ijzerman RG, Ten Kulve JS, Barkhof F, Diamant M, Veltman DJ, van Duinkerken E. Alterations in white matter volume and integrity in obesity and type 2 diabetes. Metabolic Brain Disease. PMID 26815786 DOI: 10.1007/s11011-016-9792-3  0.88
2016 Ten Kulve JS, Veltman DJ, van Bloemendaal L, Groot PF, Ruhé HG, Barkhof F, Diamant M, Ijzerman RG. Endogenous GLP-1 and GLP-1 analogue alter CNS responses to palatable food consumption. The Journal of Endocrinology. PMID 26769912 DOI: 10.1530/JOE-15-0461  0.64
2016 Zhang Y, Jonkman L, Klauser A, Barkhof F, Yong VW, Metz LM, Geurts JJ. Multi-scale MRI spectrum detects differences in myelin integrity between MS lesion types. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26754802 DOI: 10.1177/1352458515624771  0.8
2016 Popescu V, Schoonheim MM, Versteeg A, Chaturvedi N, Jonker M, Xavier de Menezes R, Gallindo Garre F, Uitdehaag BM, Barkhof F, Vrenken H. Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method. Plos One. 11: e0143942. PMID 26745873 DOI: 10.1371/journal.pone.0143942  0.8
2015 Liu Y, Dai Z, Duan Y, Huang J, Ren Z, Liu Z, Dong H, Shu N, Vrenken H, Wattjes MP, Barkhof F, He Y, Li K. Whole brain functional connectivity in clinically isolated syndrome without conventional brain MRI lesions. European Radiology. PMID 26714968 DOI: 10.1007/s00330-015-4147-8  1
2015 van Duinkerken E, Ijzerman RG, Klein M, Moll AC, Snoek FJ, Scheltens P, Pouwels PJ, Barkhof F, Diamant M, Tijms BM. Disrupted subject-specific gray matter network properties and cognitive dysfunction in type 1 diabetes patients with and without proliferative retinopathy. Human Brain Mapping. PMID 26700243 DOI: 10.1002/hbm.23096  0.88
2015 Jokinen H, Gonçalves N, Vigário R, Lipsanen J, Fazekas F, Schmidt R, Barkhof F, Madureira S, Verdelho A, Inzitari D, Pantoni L, Erkinjuntti T. Early-Stage White Matter Lesions Detected by Multispectral MRI Segmentation Predict Progressive Cognitive Decline. Frontiers in Neuroscience. 9: 455. PMID 26696814 DOI: 10.3389/fnins.2015.00455  0.88
2015 Jonkman LE, Fleysher L, Steenwijk MD, Koeleman JA, de Snoo TP, Barkhof F, Inglese M, Geurts JJ. Ultra-high field MTR and qR2* differentiates subpial cortical lesions from normal-appearing gray matter in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26672996 DOI: 10.1177/1352458515620499  0.8
2015 Hafkemeijer A, Möller C, Dopper EG, Jiskoot LC, van den Berg-Huysmans AA, van Swieten JC, van der Flier WM, Vrenken H, Pijnenburg YA, Barkhof F, Scheltens P, van der Grond J, Rombouts SA. Differences in structural covariance brain networks between behavioral variant frontotemporal dementia and Alzheimer's disease. Human Brain Mapping. PMID 26660857 DOI: 10.1002/hbm.23081  0.88
2015 Möller C, Pijnenburg YA, van der Flier WM, Versteeg A, Tijms B, de Munck JC, Hafkemeijer A, Rombouts SA, van der Grond J, van Swieten J, Dopper E, Scheltens P, Barkhof F, Vrenken H, Wink AM. Alzheimer Disease and Behavioral Variant Frontotemporal Dementia: Automatic Classification Based on Cortical Atrophy for Single-Subject Diagnosis. Radiology. 150220. PMID 26653846 DOI: 10.1148/radiol.2015150220  1
2015 Steenwijk MD, Geurts JJ, Daams M, Tijms BM, Wink AM, Balk LJ, Tewarie PK, Uitdehaag BM, Barkhof F, Vrenken H, Pouwels PJ. Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant. Brain : a Journal of Neurology. PMID 26637488 DOI: 10.1093/brain/awv337  0.88
2015 Möller C, Hafkemeijer A, Pijnenburg YA, Rombouts SA, van der Grond J, Dopper E, van Swieten J, Versteeg A, Pouwels PJ, Barkhof F, Scheltens P, Vrenken H, van der Flier WM. Joint assessment of white matter integrity, cortical and subcortical atrophy to distinguish AD from behavioral variant FTD: A two-center study. Neuroimage. Clinical. 9: 418-29. PMID 26594624 DOI: 10.1016/j.nicl.2015.08.022  0.88
2015 Rhodius-Meester HF, Koikkalainen J, Mattila J, Teunissen CE, Barkhof F, Lemstra AW, Scheltens P, Lötjönen J, van der Flier WM. Integrating Biomarkers for Underlying Alzheimer's Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual Biomarkers. Journal of Alzheimer's Disease : Jad. PMID 26577521 DOI: 10.3233/JAD-150548  0.64
2015 Steenwijk MD, Vrenken H, Jonkman LE, Daams M, Geurts JJ, Barkhof F, Pouwels PJ. High-resolution T1-relaxation time mapping displays subtle, clinically relevant, gray matter damage in long-standing multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26564997 DOI: 10.1177/1352458515615953  0.8
2015 Wattjes MP, Wijburg MT, Vennegoor A, Witte BI, Roosendaal SD, Sanchez E, Liu Y, Martins Jarnalo CO, Richert ND, Uitdehaag BM, Barkhof F, Killestein J. Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26564995 DOI: 10.1177/1352458515615225  0.88
2015 Tijms BM, Kate MT, Wink AM, Visser PJ, Ecay M, Clerigue M, Estanga A, Garcia Sebastian M, Izagirre A, Villanua J, Martinez Lage P, van der Flier WM, Scheltens P, Sanz Arigita E, Barkhof F. Gray matter network disruptions and amyloid beta in cognitively normal adults. Neurobiology of Aging. PMID 26559882 DOI: 10.1016/j.neurobiolaging.2015.10.015  1
2015 Enzinger C, Barkhof F, Ciccarelli O, Filippi M, Kappos L, Rocca MA, Ropele S, Rovira À, Schneider T, de Stefano N, Vrenken H, Wheeler-Kingshott C, Wuerfel J, Fazekas F. Nonconventional MRI and microstructural cerebral changes in multiple sclerosis. Nature Reviews. Neurology. PMID 26526531 DOI: 10.1038/nrneurol.2015.194  0.88
2015 Gardeniers M, Wattjes MP, Meulen EF, Barkhof F, Bakker J. [Diagnostic imaging in dementia: use of imaging modalities in Dutch memory clinics]. Tijdschrift Voor Gerontologie En Geriatrie. PMID 26525706 DOI: 10.1007/s12439-015-0154-0  0.84
2015 Krudop WA, Dols A, Kerssens CJ, Prins ND, Möller C, Schouws S, Barkhof F, van Berckel BN, Teunissen CE, van der Flier WM, Scheltens P, Sikkes SA, Stek ML, Pijnenburg YA. Impact of Imaging and Cerebrospinal Fluid Biomarkers on Behavioral Variant Frontotemporal Dementia Diagnosis within a Late-Onset Frontal Lobe Syndrome Cohort. Dementia and Geriatric Cognitive Disorders. 41: 16-26. PMID 26473985 DOI: 10.1159/000441023  0.64
2015 Cohen J, Belova A, Selmaj K, Wolf C, Sormani MP, Oberyé J, van den Tweel E, Mulder R, Koper N, Voortman G, Barkhof F. Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis: A Randomized Clinical Trial. Jama Neurology. 1-9. PMID 26458034 DOI: 10.1001/jamaneurol.2015.2154  0.88
2015 Munger KL, Fitzgerald KC, Freedman MS, Hartung HP, Miller DH, Montalbán X, Edan G, Barkhof F, Suarez G, Radue EW, Sandbrink R, Kappos L, Pohl C, Ascherio A. No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT. Neurology. 85: 1694-701. PMID 26453645 DOI: 10.1212/WNL.0000000000002099  0.88
2015 Hafkemeijer A, Möller C, Dopper EG, Jiskoot LC, Schouten TM, van Swieten JC, van der Flier WM, Vrenken H, Pijnenburg YA, Barkhof F, Scheltens P, van der Grond J, Rombouts SA. Resting state functional connectivity differences between behavioral variant frontotemporal dementia and Alzheimer's disease. Frontiers in Human Neuroscience. 9: 474. PMID 26441584 DOI: 10.3389/fnhum.2015.00474  0.88
2015 Tillema JM, Hulst HE, Rocca MA, Vrenken H, Steenwijk MD, Damjanovic D, Enzinger C, Ropele S, Tedeschi G, Gallo A, Ciccarelli O, Rovira A, Montalban X, de Stefano N, Stromillo ML, ... ... Barkhof F, et al. Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26432859 DOI: 10.1177/1352458515607650  0.8
2015 Liu Y, Fu Y, Schoonheim MM, Zhang N, Fan M, Su L, Shen Y, Yan Y, Yang L, Wang Q, Zhang N, Yu C, Barkhof F, Shi FD. Structural MRI substrates of cognitive impairment in neuromyelitis optica. Neurology. PMID 26423432 DOI: 10.1212/WNL.0000000000002067  0.8
2015 Adriaanse SM, Wink AM, Tijms BM, Ossenkoppele R, Verfaillie S, Lammertsma AA, Boellaard R, Scheltens P, van Berckel BN, Barkhof F. The association of glucose metabolism and eigenvector centrality in Alzheimer's disease. Brain Connectivity. PMID 26414628 DOI: 10.1089/brain.2014.0320  1
2015 Duits FH, Hernandez-Guillamon M, Montaner J, Goos JD, Montañola A, Wattjes MP, Barkhof F, Scheltens P, Teunissen CE, van der Flier WM. Matrix Metalloproteinases in Alzheimer's Disease and Concurrent Cerebral Microbleeds. Journal of Alzheimer's Disease : Jad. PMID 26402072 DOI: 10.3233/JAD-143186  0.64
2015 Brueggen K, Dyrba M, Barkhof F, Hausner L, Filippi M, Nestor PJ, Hauenstein K, Klöppel S, Grothe MJ, Kasper E, Teipel SJ. Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study. Journal of Alzheimer's Disease : Jad. 48: 197-204. PMID 26401940 DOI: 10.3233/JAD-150063  0.88
2015 Tillema JM, Derks MG, Pouwels PJ, de Graaf P, van Rappard DF, Barkhof F, Steenweg ME, van der Knaap MS, Wolf NI. Volumetric MRI data correlate to disease severity in metachromatic leukodystrophy. Annals of Clinical and Translational Neurology. 2: 932-40. PMID 26401514 DOI: 10.1002/acn3.232  0.8
2015 Ten Kulve JS, Veltman DJ, van Bloemendaal L, Barkhof F, Deacon CF, Holst JJ, Konrad RJ, Sloan JH, Drent ML, Diamant M, IJzerman RG. Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes. Diabetologia. PMID 26385462 DOI: 10.1007/s00125-015-3754-x  0.64
2015 Wattjes MP, Wijburg MT, Vennegoor A, Witte BI, de Vos M, Richert ND, Uitdehaag BM, Barkhof F, Killestein J. MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 26369555 DOI: 10.1136/jnnp-2015-311411  0.88
2015 Wattjes MP, Rovira À, Miller D, Yousry TA, Sormani MP, de Stefano N, Tintoré M, Auger C, Tur C, Filippi M, Rocca MA, Fazekas F, Kappos L, Polman C, Barkhof F, et al. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-establishing disease prognosis and monitoring patients. Nature Reviews. Neurology. PMID 26369511 DOI: 10.1038/nrneurol.2015.157  0.88
2015 van Bloemendaal L, Veltman DJ, Ten Kulve JS, Drent ML, Barkhof F, Diamant M, IJzerman RG. Emotional eating is associated with increased brain responses to food-cues and reduced sensitivity to GLP-1 receptor activation. Obesity (Silver Spring, Md.). PMID 26331843 DOI: 10.1002/oby.21200  0.64
2015 Ten Kulve JS, Veltman DJ, van Bloemendaal L, Barkhof F, Drent ML, Diamant M, IJzerman RG. Liraglutide Reduces CNS Activation in Response to Visual Food Cues Only After Short-term Treatment in Patients With Type 2 Diabetes. Diabetes Care. PMID 26283736 DOI: 10.2337/dc15-0772  0.64
2015 Ossenkoppele R, Cohn-Sheehy BI, La Joie R, Vogel JW, Möller C, Lehmann M, van Berckel BN, Seeley WW, Pijnenburg YA, Gorno-Tempini ML, Kramer JH, Barkhof F, Rosen HJ, van der Flier WM, Jagust WJ, et al. Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease. Human Brain Mapping. PMID 26260856 DOI: 10.1002/hbm.22927  1
2015 Daams M, Steenwijk MD, Schoonheim MM, Wattjes MP, Balk LJ, Tewarie PK, Killestein J, Uitdehaag BM, Geurts JJ, Barkhof F. Multi-parametric structural magnetic resonance imaging in relation to cognitive dysfunction in long-standing multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26209593 DOI: 10.1177/1352458515596598  0.84
2015 Oudega ML, Dols A, Adelerhof I, Rozing M, Wattjes MP, Comijs HC, Barkhof F, Eikelenboom P, Stek ML, van Exel E. Contribution of white matter hyperintensities, medial temporal lobe atrophy and cortical atrophy on outcome, seven to twelve years after ECT in severely depressed geriatric patients. Journal of Affective Disorders. 185: 144-8. PMID 26186529 DOI: 10.1016/j.jad.2015.07.011  0.88
2015 Benedictus MR, van Harten AC, Leeuwis AE, Koene T, Scheltens P, Barkhof F, Prins ND, van der Flier WM. White Matter Hyperintensities Relate to Clinical Progression in Subjective Cognitive Decline. Stroke; a Journal of Cerebral Circulation. 46: 2661-4. PMID 26173729 DOI: 10.1161/STROKEAHA.115.009475  0.88
2015 Jovicich J, Minati L, Marizzoni M, Marchitelli R, Sala-Llonch R, Bartrés-Faz D, Arnold J, Benninghoff J, Fiedler U, Roccatagliata L, Picco A, Nobili F, Blin O, Bombois S, Lopes R, et al. Longitudinal reproducibility of default-mode network connectivity in healthy elderly participants: A multicentric resting-state fMRI study. Neuroimage. PMID 26163799 DOI: 10.1016/j.neuroimage.2015.07.010  0.84
2015 Rovira À, Wattjes MP, Tintoré M, Tur C, Yousry TA, Sormani MP, De Stefano N, Filippi M, Auger C, Rocca MA, Barkhof F, Fazekas F, Kappos L, Polman C, Miller D, et al. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process. Nature Reviews. Neurology. 11: 471-82. PMID 26149978 DOI: 10.1038/nrneurol.2015.106  0.84
2015 Ossenkoppele R, Pijnenburg YA, Perry DC, Cohn-Sheehy BI, Scheltens NM, Vogel JW, Kramer JH, van der Vlies AE, Joie RL, Rosen HJ, van der Flier WM, Grinberg LT, Rozemuller AJ, Huang EJ, van Berckel BN, ... ... Barkhof F, et al. The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features. Brain : a Journal of Neurology. 138: 2732-49. PMID 26141491 DOI: 10.1093/brain/awv191  0.88
2015 Daams M, Steenwijk MD, Wattjes MP, Geurts JJ, Uitdehaag BM, Tewarie PK, Balk LJ, Pouwels PJ, Killestein J, Barkhof F. Unraveling the neuroimaging predictors for motor dysfunction in long-standing multiple sclerosis. Neurology. 85: 248-55. PMID 26115736 DOI: 10.1212/WNL.0000000000001756  0.88
2015 Geytenbeek JJ, Oostrom KJ, Harlaar L, Becher JG, Knol DL, Barkhof F, Pinto PS, Vermeulen RJ. Language comprehension in nonspeaking children with severe cerebral palsy: Neuroanatomical substrate? European Journal of Paediatric Neurology : Ejpn : Official Journal of the European Paediatric Neurology Society. 19: 510-20. PMID 26112263 DOI: 10.1016/j.ejpn.2015.06.001  0.88
2015 Cohen JA, Khatri B, Barkhof F, Comi G, Hartung HP, Montalban X, Pelletier J, Stites T, Ritter S, von Rosenstiel P, Tomic D, Kappos L. Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 26111826 DOI: 10.1136/jnnp-2015-310597  0.48
2015 Jain S, Sima DM, Ribbens A, Cambron M, Maertens A, Van Hecke W, De Mey J, Barkhof F, Steenwijk MD, Daams M, Maes F, Van Huffel S, Vrenken H, Smeets D. Automatic segmentation and volumetry of multiple sclerosis brain lesions from MR images. Neuroimage. Clinical. 8: 367-75. PMID 26106562 DOI: 10.1016/j.nicl.2015.05.003  0.8
2015 van Bloemendaal L, Veltman DJ, Ten Kulve JS, Groot PF, Ruhé HG, Barkhof F, Sloan JH, Diamant M, Ijzerman RG. Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon-like peptide-1 receptor activation in humans. Diabetes, Obesity & Metabolism. 17: 878-86. PMID 26094857 DOI: 10.1111/dom.12506  1
2015 Marizzoni M, Antelmi L, Bosch B, Bartrés-Faz D, Müller BW, Wiltfang J, Fiedler U, Roccatagliata L, Picco A, Nobili F, Blin O, Bombois S, Lopes R, Sein J, Ranjeva JP, ... ... Barkhof F, et al. Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly. Human Brain Mapping. 36: 3516-27. PMID 26043939 DOI: 10.1002/hbm.22859  0.84
2015 Liu Y, Duan Y, Huang J, Ren Z, Ye J, Dong H, Shi FD, Barkhof F, Vrenken H, Wattjes MP, Wang J, Li K. Multimodal Quantitative MR Imaging of the Thalamus in Multiple Sclerosis and Neuromyelitis Optica. Radiology. 142786. PMID 26043265 DOI: 10.1148/radiol.2015142786  0.88
2015 Binnewijzend MA, Benedictus MR, Kuijer JP, van der Flier WM, Teunissen CE, Prins ND, Wattjes MP, van Berckel BN, Scheltens P, Barkhof F. Cerebral perfusion in the predementia stages of Alzheimer's disease. European Radiology. PMID 26040647 DOI: 10.1007/s00330-015-3834-9  1
2015 Ossenkoppele R, Mattsson N, Teunissen CE, Barkhof F, Pijnenburg Y, Scheltens P, van der Flier WM, Rabinovici GD. Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer's disease. Neurobiology of Aging. 36: 2340-7. PMID 25990306 DOI: 10.1016/j.neurobiolaging.2015.04.011  0.88
2015 Ossenkoppele R, Jansen WJ, Rabinovici GD, Knol DL, van der Flier WM, van Berckel BN, Scheltens P, Visser PJ, Verfaillie SC, Zwan MD, Adriaanse SM, Lammertsma AA, Barkhof F, Jagust WJ, et al. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. Jama. 313: 1939-49. PMID 25988463 DOI: 10.1001/jama.2015.4669  1
2015 Yi HA, Möller C, Dieleman N, Bouwman FH, Barkhof F, Scheltens P, van der Flier WM, Vrenken H. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 25904810 DOI: 10.1136/jnnp-2014-309105  1
2015 Verfaillie SC, Adriaanse SM, Binnewijzend MA, Benedictus MR, Ossenkoppele R, Wattjes MP, Pijnenburg YA, van der Flier WM, Lammertsma AA, Kuijer JP, Boellaard R, Scheltens P, van Berckel BN, Barkhof F. Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin? European Radiology. PMID 25899416 DOI: 10.1007/s00330-015-3696-1  0.88
2015 Bisecco A, Rocca MA, Pagani E, Mancini L, Enzinger C, Gallo A, Vrenken H, Stromillo ML, Copetti M, Thomas DL, Fazekas F, Tedeschi G, Barkhof F, Stefano ND, Filippi M, et al. Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study. Human Brain Mapping. 36: 2809-25. PMID 25873194 DOI: 10.1002/hbm.22809  1
2015 Harper L, Barkhof F, Fox NC, Schott JM. Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 25872513 DOI: 10.1136/jnnp-2014-310090  0.88
2015 Barkhof F, Geurts JJ. Laminar cortical damage in multiple sclerosis. Brain : a Journal of Neurology. 138: 828-9. PMID 25802316 DOI: 10.1093/brain/awv031  0.88
2015 Benedictus MR, Prins ND, Goos JD, Scheltens P, Barkhof F, van der Flier WM. Microbleeds, Mortality, and Stroke in Alzheimer Disease: The MISTRAL Study. Jama Neurology. 72: 539-45. PMID 25798556 DOI: 10.1001/jamaneurol.2015.14  0.88
2015 Scheltens NM, Galindo-Garre F, Pijnenburg YA, van der Vlies AE, Smits LL, Koene T, Teunissen CE, Barkhof F, Wattjes MP, Scheltens P, van der Flier WM. The identification of cognitive subtypes in Alzheimer's disease dementia using latent class analysis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 25783437 DOI: 10.1136/jnnp-2014-309582  0.88
2015 Redolfi A, Manset D, Barkhof F, Wahlund LO, Glatard T, Mangin JF, Frisoni GB. Head-to-head comparison of two popular cortical thickness extraction algorithms: a cross-sectional and longitudinal study. Plos One. 10: e0117692. PMID 25781983 DOI: 10.1371/journal.pone.0117692  0.88
2015 Liu Y, Wang J, Daams M, Weiler F, Hahn HK, Duan Y, Huang J, Ren Z, Ye J, Dong H, Vrenken H, Wattjes MP, Shi FD, Li K, Barkhof F. Differential patterns of spinal cord and brain atrophy in NMO and MS. Neurology. 84: 1465-72. PMID 25762714 DOI: 10.1212/WNL.0000000000001441  0.88
2015 Jonkman LE, Soriano AL, Amor S, Barkhof F, van der Valk P, Vrenken H, Geurts JJ. Can MS lesion stages be distinguished with MRI? A postmortem MRI and histopathology study. Journal of Neurology. 262: 1074-80. PMID 25761376 DOI: 10.1007/s00415-015-7689-4  0.88
2015 Gass A, Rocca MA, Agosta F, Ciccarelli O, Chard D, Valsasina P, Brooks JC, Bischof A, Eisele P, Kappos L, Barkhof F, Filippi M. MRI monitoring of pathological changes in the spinal cord in patients with multiple sclerosis. The Lancet. Neurology. 14: 443-54. PMID 25748099 DOI: 10.1016/S1474-4422(14)70294-7  0.88
2015 Wiebenga OT, Klauser AM, Schoonheim MM, Nagtegaal GJ, Steenwijk MD, van Rossum JA, Polman CH, Barkhof F, Pouwels PJ, Geurts JJ. Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis. Ajnr. American Journal of Neuroradiology. 36: 1116-23. PMID 25742985 DOI: 10.3174/ajnr.A4252  0.88
2015 van Schie PE, Schijns J, Becher JG, Barkhof F, van Weissenbruch MM, Vermeulen RJ. Long-term motor and behavioral outcome after perinatal hypoxic-ischemic encephalopathy. European Journal of Paediatric Neurology : Ejpn : Official Journal of the European Paediatric Neurology Society. 19: 354-9. PMID 25683783 DOI: 10.1016/j.ejpn.2015.01.005  0.88
2015 Hulst HE, Schoonheim MM, Van Geest Q, Uitdehaag BM, Barkhof F, Geurts JJ. Memory impairment in multiple sclerosis: Relevance of hippocampal activation and hippocampal connectivity. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 25680986 DOI: 10.1177/1352458514567727  1
2015 Arrighi HM, Barakos J, Barkhof F, Tampieri D, Jack C, Melançon D, Morris K, Ketter N, Liu E, Brashear HR. Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer's disease treated with bapineuzumab: a historical, prospective secondary analysis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 25669746 DOI: 10.1136/jnnp-2014-309493  0.88
2015 Louwersheimer E, Ramirez A, Cruchaga C, Becker T, Kornhuber J, Peters O, Heilmann S, Wiltfang J, Jessen F, Visser PJ, Scheltens P, Pijnenburg YA, Teunissen CE, Barkhof F, van Swieten JC, et al. The influence of genetic variants in SORL1 gene on the manifestation of Alzheimer's disease. Neurobiology of Aging. 36: 1605.e13-20. PMID 25659857 DOI: 10.1016/j.neurobiolaging.2014.12.007  0.88
2015 Bron EE, Smits M, van der Flier WM, Vrenken H, Barkhof F, Scheltens P, Papma JM, Steketee RM, Méndez Orellana C, Meijboom R, Pinto M, Meireles JR, Garrett C, Bastos-Leite AJ, Abdulkadir A, et al. Standardized evaluation of algorithms for computer-aided diagnosis of dementia based on structural MRI: the CADDementia challenge. Neuroimage. 111: 562-79. PMID 25652394 DOI: 10.1016/j.neuroimage.2015.01.048  0.88
2015 Prestia A, Caroli A, Wade SK, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall A, Carter SF, Schöll M, Choo IH, Nordberg A, Scheltens P, Frisoni GB. Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 25646957 DOI: 10.1016/j.jalz.2014.12.001  0.88
2015 Dyrba M, Barkhof F, Fellgiebel A, Filippi M, Hausner L, Hauenstein K, Kirste T, Teipel SJ. Predicting Prodromal Alzheimer's Disease in Subjects with Mild Cognitive Impairment Using Machine Learning Classification of Multimodal Multicenter Diffusion-Tensor and Magnetic Resonance Imaging Data. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 25644739 DOI: 10.1111/jon.12214  1
2015 Radue EW, Barkhof F, Kappos L, Sprenger T, Häring DA, de Vera A, von Rosenstiel P, Bright JR, Francis G, Cohen JA. Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis. Neurology. 84: 784-93. PMID 25632085 DOI: 10.1212/WNL.0000000000001281  0.88
2015 Steenwijk MD, Daams M, Pouwels PJ, J Balk L, Tewarie PK, Geurts JJ, Barkhof F, Vrenken H. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis. Human Brain Mapping. 36: 1796-807. PMID 25627545 DOI: 10.1002/hbm.22738  0.88
2015 Schoonheim MM, Hulst HE, Brandt RB, Strik M, Wink AM, Uitdehaag BM, Barkhof F, Geurts JJ. Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis. Neurology. 84: 776-83. PMID 25616483 DOI: 10.1212/WNL.0000000000001285  0.88
2015 Barkhof F, Reich DS. Can leptomeningeal enhancement be linked to multiple sclerosis? Neurology. 84: 762-3. PMID 25616481 DOI: 10.1212/WNL.0000000000001292  0.88
2015 Popescu V, Klaver R, Voorn P, Galis-de Graaf Y, Knol D, Twisk J, Versteeg A, Schenk G, Van der Valk P, Barkhof F, De Vries H, Vrenken H, Geurts J. What drives MRI-measured cortical atrophy in multiple sclerosis? Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 25583833 DOI: 10.1177/1352458514562440  1
2015 Caroli A, Prestia A, Galluzzi S, Ferrari C, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen C, Wall AE, Carter SF, Schöll M, Choo IH, Grimmer T, Redolfi A, et al. Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression. Neurology. 84: 508-15. PMID 25568301 DOI: 10.1212/WNL.0000000000001209  0.88
2015 Roosendaal SD, Barkhof F. Imaging phenotypes in multiple sclerosis. Neuroimaging Clinics of North America. 25: 83-96. PMID 25476514 DOI: 10.1016/j.nic.2014.09.008  1
2015 Möller C, Dieleman N, van der Flier WM, Versteeg A, Pijnenburg Y, Scheltens P, Barkhof F, Vrenken H. More atrophy of deep gray matter structures in frontotemporal dementia compared to Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 44: 635-47. PMID 25322925 DOI: 10.3233/JAD-141230  1
2015 Tewarie P, Schoonheim MM, Schouten DI, Polman CH, Balk LJ, Uitdehaag BM, Geurts JJ, Hillebrand A, Barkhof F, Stam CJ. Functional brain networks: linking thalamic atrophy to clinical disability in multiple sclerosis, a multimodal fMRI and MEG study. Human Brain Mapping. 36: 603-18. PMID 25293505 DOI: 10.1002/hbm.22650  0.88
2015 Xekardaki A, Rodriguez C, Montandon ML, Toma S, Tombeur E, Herrmann FR, Zekry D, Lovblad KO, Barkhof F, Giannakopoulos P, Haller S. Arterial spin labeling may contribute to the prediction of cognitive deterioration in healthy elderly individuals. Radiology. 274: 490-9. PMID 25291458 DOI: 10.1148/radiol.14140680  0.88
2015 Frisoni GB, Jack CR, Bocchetta M, Bauer C, Frederiksen KS, Liu Y, Preboske G, Swihart T, Blair M, Cavedo E, Grothe MJ, Lanfredi M, Martinez O, Nishikawa M, Portegies M, ... ... Barkhof F, et al. The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: evidence of validity. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 111-25. PMID 25267715 DOI: 10.1016/j.jalz.2014.05.1756  0.88
2015 Haller S, Barkhof F, Wattjes MP, Lalive PH. Transient gadolinium leakage in natalizumab-treated multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 86: 475-6. PMID 25246642 DOI: 10.1136/jnnp-2014-309069  0.88
2015 Wattjes MP, Vennegoor A, Steenwijk MD, de Vos M, Killestein J, van Oosten BW, Mostert J, Siepman DA, Moll W, van Golde AE, Frequin ST, Richert ND, Barkhof F. MRI pattern in asymptomatic natalizumab-associated PML. Journal of Neurology, Neurosurgery, and Psychiatry. 86: 793-8. PMID 25205744 DOI: 10.1136/jnnp-2014-308630  0.88
2015 Richiardi J, Monsch AU, Haas T, Barkhof F, Van de Ville D, Radü EW, Kressig RW, Haller S. Altered cerebrovascular reactivity velocity in mild cognitive impairment and Alzheimer's disease. Neurobiology of Aging. 36: 33-41. PMID 25146454 DOI: 10.1016/j.neurobiolaging.2014.07.020  1
2015 van Rooden S, Doan NT, Versluis MJ, Goos JD, Webb AG, Oleksik AM, van der Flier WM, Scheltens P, Barkhof F, Weverling-Rynsburger AW, Blauw GJ, Reiber JH, van Buchem MA, Milles J, van der Grond J. 7T T₂*-weighted magnetic resonance imaging reveals cortical phase differences between early- and late-onset Alzheimer's disease. Neurobiology of Aging. 36: 20-6. PMID 25113794 DOI: 10.1016/j.neurobiolaging.2014.07.006  1
2015 Kilsdonk ID, Steenwijk MD, Pouwels PJ, Zwanenburg JJ, Visser F, Luijten PR, Geurts J, Barkhof F, Wattjes MP. Perivascular spaces in MS patients at 7 Tesla MRI: a marker of neurodegeneration? Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 155-62. PMID 25013150 DOI: 10.1177/1352458514540358  1
2015 Balk LJ, Steenwijk MD, Tewarie P, Daams M, Killestein J, Wattjes MP, Vrenken H, Barkhof F, Polman CH, Uitdehaag BM, Petzold A. Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 86: 419-24. PMID 24973342 DOI: 10.1136/jnnp-2014-308189  0.88
2015 Lukas C, Knol DL, Sombekke MH, Bellenberg B, Hahn HK, Popescu V, Weier K, Radue EW, Gass A, Kappos L, Naegelin Y, Uitdehaag BM, Geurts JJ, Barkhof F, Vrenken H. Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 86: 410-8. PMID 24973341 DOI: 10.1136/jnnp-2014-308021  0.88
2015 van Straaten EC, den Haan J, de Waal H, van der Flier WM, Barkhof F, Prins ND, Stam CJ. Disturbed phase relations in white matter hyperintensity based vascular dementia: an EEG directed connectivity study. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 126: 497-504. PMID 24969377 DOI: 10.1016/j.clinph.2014.05.018  1
2015 Lalive PH, Bridel C, Ferfoglia RI, Kaiser L, Du Pasquier R, Barkhof F, Haller S. Minimal supportive treatment in natalizumab-related PML in a MS patient. Journal of Neurology, Neurosurgery, and Psychiatry. 86: 354-5. PMID 24957322 DOI: 10.1136/jnnp-2014-308154  0.88
2015 Jansen MH, Veldhuijzen van Zanten SE, Sanchez Aliaga E, Heymans MW, Warmuth-Metz M, Hargrave D, van der Hoeven EJ, Gidding CE, de Bont ES, Eshghi OS, Reddingius R, Peeters CM, Schouten-van Meeteren AY, Gooskens RH, Granzen B, ... ... Barkhof F, et al. Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria. Neuro-Oncology. 17: 160-6. PMID 24903904 DOI: 10.1093/neuonc/nou104  0.84
2015 Macfarlane MD, Looi JC, Walterfang M, Spulber G, Velakoulis D, Styner M, Crisby M, Orndahl E, Erkinjuntti T, Waldemar G, Garde E, Hennerici MG, Bäzner H, Blahak C, Wallin A, et al. Shape abnormalities of the caudate nucleus correlate with poorer gait and balance: results from a subset of the LADIS study. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 23: 59-71.e1. PMID 23916546 DOI: 10.1016/j.jagp.2013.04.011  0.88
2015 Weiler F, Daams M, Lukas C, Barkhof F, Hahn HK. Highly accurate volumetry of the spinal cord Progress in Biomedical Optics and Imaging - Proceedings of Spie. 9413. DOI: 10.1117/12.2080803  0.88
2015 Rovira À, Wattjes MP, Tintoré M, Tur C, Yousry TA, Sormani MP, de Stefano N, Filippi M, Auger C, Rocca MA, Barkhof F, Fazekas F, Kappos L, Polman C, Miller D, et al. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process Nature Reviews Neurology. DOI: 10.1038/nrneurol.2015.106  0.88
2015 Jain S, Sima DM, Ribbens A, Cambron M, Maertens A, Van Hecke W, De Mey J, Barkhof F, Steenwijk MD, Daams M, Maes F, Van Huffel S, Vrenken H, Smeets D. Automatic segmentation and volumetry of multiple sclerosis brain lesions from MR images Neuroimage: Clinical. 8: 367-375. DOI: 10.1016/j.nicl.2015.05.003  0.88
2015 Marizzoni M, Antelmi L, Bosch B, Bartrés-Faz D, Müller BW, Wiltfang J, Fiedler U, Roccatagliata L, Picco A, Nobili F, Blin O, Bombois S, Lopes R, Sein J, Ranjeva JP, ... ... Barkhof F, et al. Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly Human Brain Mapping. DOI: 10.1002/hbm.22859  0.84
2014 Freedman MS, Comi G, De Stefano N, Barkhof F, Polman CH, Uitdehaag BM, Lehr L, Stubinski B, Kappos L. Moving toward earlier treatment of multiple sclerosis: Findings from a decade of clinical trials and implications for clinical practice. Multiple Sclerosis and Related Disorders. 3: 147-55. PMID 25878002 DOI: 10.1016/j.msard.2013.07.001  1
2014 Khatri BO, Pelletier J, Kappos L, Hartung HP, Comi G, Barkhof F, von Rosenstiel P, Meng X, Grinspan A, Hashmonay R, Cohen JA. Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS). Multiple Sclerosis and Related Disorders. 3: 355-63. PMID 25876473 DOI: 10.1016/j.msard.2013.11.006  1
2014 Aalten P, Ramakers IH, Biessels GJ, de Deyn PP, Koek HL, OldeRikkert MG, Oleksik AM, Richard E, Smits LL, van Swieten JC, Teune LK, van der Lugt A, Barkhof F, Teunissen CE, Rozendaal N, et al. The Dutch Parelsnoer Institute - Neurodegenerative diseases; methods, design and baseline results. Bmc Neurology. 14: 254. PMID 25551191 DOI: 10.1186/s12883-014-0254-4  0.88
2014 van Rooden S, Buijs M, van Vliet ME, Versluis MJ, Webb AG, Oleksik AM, van de Wiel L, Middelkoop HA, Blauw GJ, Weverling-Rynsburger AW, Goos JD, van der Flier WM, Koene T, Scheltens P, Barkhof F, et al. Cortical phase changes measured using 7-T MRI in subjects with subjective cognitive impairment, and their association with cognitive function. Nmr in Biomedicine. PMID 25522735 DOI: 10.1002/nbm.3248  0.88
2014 Prins ND, van der Flier WA, Knol DL, Fox NC, Brashear HR, Nye JS, Barkhof F, Scheltens P. The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial. Alzheimer's Research & Therapy. 6: 47. PMID 25478019 DOI: 10.1186/alzrt275  0.88
2014 Barkhof F. Spinal cord MRI should always be performed in clinically isolated syndrome patients: Yes. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1688-9. PMID 25395548 DOI: 10.1177/1352458514546518  0.88
2014 Olde Dubbelink KT, Schoonheim MM, Deijen JB, Twisk JW, Barkhof F, Berendse HW. Functional connectivity and cognitive decline over 3 years in Parkinson disease. Neurology. 83: 2046-53. PMID 25355821 DOI: 10.1212/WNL.0000000000001020  0.88
2014 Tran JQ, Rana J, Barkhof F, Melamed I, Gevorkyan H, Wattjes MP, de Jong R, Brosofsky K, Ray S, Xu L, Zhao J, Parr E, Cadavid D. Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033. Neurology® Neuroimmunology & Neuroinflammation. 1: e18. PMID 25340070 DOI: 10.1212/NXI.0000000000000018  0.84
2014 Munger KL, Köchert K, Simon KC, Kappos L, Polman CH, Freedman MS, Hartung HP, Miller DH, Montalbán X, Edan G, Barkhof F, Pleimes D, Sandbrink R, Ascherio A, Pohl C. Molecular mechanism underlying the impact of vitamin D on disease activity of MS. Annals of Clinical and Translational Neurology. 1: 605-17. PMID 25285313 DOI: 10.1002/acn3.91  0.8
2014 Limmroth V, Barkhof F, Desem N, Diamond MP, Tachas G. CD49d antisense drug ATL1102 reduces disease activity in patients with relapsing-remitting MS. Neurology. 83: 1780-8. PMID 25239835 DOI: 10.1212/WNL.0000000000000926  1
2014 Cover KS, van Schijndel RA, Popescu V, van Dijk BW, Redolfi A, Knol DL, Frisoni GB, Barkhof F, Vrenken H. The SIENA/FSL whole brain atrophy algorithm is no more reproducible at 3T than 1.5 T for Alzheimer's disease. Psychiatry Research. 224: 14-21. PMID 25089020 DOI: 10.1016/j.pscychresns.2014.07.002  0.88
2014 Adriaanse SM, Binnewijzend MA, Ossenkoppele R, Tijms BM, van der Flier WM, Koene T, Smits LL, Wink AM, Scheltens P, van Berckel BN, Barkhof F. Widespread disruption of functional brain organization in early-onset Alzheimer's disease. Plos One. 9: e102995. PMID 25080229 DOI: 10.1371/journal.pone.0102995  1
2014 Hoefnagels FW, De Witt Hamer P, Sanz-Arigita E, Idema S, Kuijer JP, Pouwels PJ, Barkhof F, Vandertop WP. Differentiation of edema and glioma infiltration: proposal of a DTI-based probability map. Journal of Neuro-Oncology. 120: 187-98. PMID 25079117 DOI: 10.1007/s11060-014-1544-9  1
2014 van Bloemendaal L, IJzerman RG, Ten Kulve JS, Barkhof F, Konrad RJ, Drent ML, Veltman DJ, Diamant M. GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans. Diabetes. 63: 4186-96. PMID 25071023 DOI: 10.2337/db14-0849  1
2014 Tewarie P, Steenwijk MD, Tijms BM, Daams M, Balk LJ, Stam CJ, Uitdehaag BM, Polman CH, Geurts JJ, Barkhof F, Pouwels PJ, Vrenken H, Hillebrand A. Disruption of structural and functional networks in long-standing multiple sclerosis. Human Brain Mapping. 35: 5946-61. PMID 25053254 DOI: 10.1002/hbm.22596  1
2014 Rocca MA, Valsasina P, Hulst HE, Abdel-Aziz K, Enzinger C, Gallo A, Pareto D, Riccitelli G, Muhlert N, Ciccarelli O, Barkhof F, Fazekas F, Tedeschi G, Arévalo MJ, Filippi M, et al. Functional correlates of cognitive dysfunction in multiple sclerosis: A multicenter fMRI Study. Human Brain Mapping. 35: 5799-814. PMID 25045065 DOI: 10.1002/hbm.22586  0.88
2014 Ouwens DM, van Duinkerken E, Schoonenboom SN, Herzfeld de Wiza D, Klein M, van Golen L, Pouwels PJ, Barkhof F, Moll AC, Snoek FJ, Teunissen CE, Scheltens P, Diamant M. Cerebrospinal fluid levels of Alzheimer's disease biomarkers in middle-aged patients with type 1 diabetes. Diabetologia. 57: 2208-14. PMID 25034377 DOI: 10.1007/s00125-014-3333-6  0.88
2014 Benedictus MR, Binnewijzend MA, Kuijer JP, Steenwijk MD, Versteeg A, Vrenken H, Scheltens P, Barkhof F, van der Flier WM, Prins ND. Brain volume and white matter hyperintensities as determinants of cerebral blood flow in Alzheimer's disease. Neurobiology of Aging. 35: 2665-70. PMID 25018106 DOI: 10.1016/j.neurobiolaging.2014.06.001  1
2014 Ciccarelli O, Barkhof F, Bodini B, De Stefano N, Golay X, Nicolay K, Pelletier D, Pouwels PJ, Smith SA, Wheeler-Kingshott CA, Stankoff B, Yousry T, Miller DH. Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging. The Lancet. Neurology. 13: 807-22. PMID 25008549 DOI: 10.1016/S1474-4422(14)70101-2  1
2014 Demuru M, van Duinkerken E, Fraschini M, Marrosu F, Snoek FJ, Barkhof F, Klein M, Diamant M, Hillebrand A. Changes in MEG resting-state networks are related to cognitive decline in type 1 diabetes mellitus patients. Neuroimage. Clinical. 5: 69-76. PMID 25003029 DOI: 10.1016/j.nicl.2014.06.001  1
2014 Binnewijzend MA, Kuijer JP, van der Flier WM, Benedictus MR, Möller CM, Pijnenburg YA, Lemstra AW, Prins ND, Wattjes MP, van Berckel BN, Scheltens P, Barkhof F. Distinct perfusion patterns in Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies. European Radiology. 24: 2326-33. PMID 24996793 DOI: 10.1007/s00330-014-3172-3  1
2014 van Duinkerken E, Schoonheim MM, Steenwijk MD, Klein M, IJzerman RG, Moll AC, Heymans MW, Snoek FJ, Barkhof F, Diamant M. Ventral striatum, but not cortical volume loss, is related to cognitive dysfunction in type 1 diabetic patients with and without microangiopathy. Diabetes Care. 37: 2483-90. PMID 24973436 DOI: 10.2337/dc14-0016  1
2014 Barkhof F, Haller S, Rombouts SA. Resting-state functional MR imaging: a new window to the brain. Radiology. 272: 29-49. PMID 24956047 DOI: 10.1148/radiol.14132388  1
2014 Maude RJ, Barkhof F, Hassan MU, Ghose A, Hossain A, Abul Faiz M, Choudhury E, Rashid R, Abu Sayeed A, Charunwatthana P, Plewes K, Kingston H, Maude RR, Silamut K, Day NP, et al. Magnetic resonance imaging of the brain in adults with severe falciparum malaria. Malaria Journal. 13: 177. PMID 24884982 DOI: 10.1186/1475-2875-13-177  1
2014 Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B, Calabresi PA, Clanet M, Comi G, Fox RJ, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 83: 278-86. PMID 24871874 DOI: 10.1212/WNL.0000000000000560  1
2014 Kester MI, Goos JD, Teunissen CE, Benedictus MR, Bouwman FH, Wattjes MP, Barkhof F, Scheltens P, van der Flier WM. Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers. Jama Neurology. 71: 855-62. PMID 24818585 DOI: 10.1001/jamaneurol.2014.754  1
2014 Barkhof F, de Jong R, Sfikas N, de Vera A, Francis G, Cohen J. The influence of patient demographics, disease characteristics and treatment on brain volume loss in Trial Assessing Injectable Interferon vs FTY720 Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS), a phase 3 study of fingolimod in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1704-13. PMID 24812043 DOI: 10.1177/1352458514532317  0.88
2014 Daams M, Weiler F, Steenwijk MD, Hahn HK, Geurts JJ, Vrenken H, van Schijndel RA, Balk LJ, Tewarie PK, Tillema JM, Killestein J, Uitdehaag BM, Barkhof F. Mean upper cervical cord area (MUCCA) measurement in long-standing multiple sclerosis: relation to brain findings and clinical disability. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1860-5. PMID 24812042 DOI: 10.1177/1352458514533399  1
2014 Ropele S, Kilsdonk ID, Wattjes MP, Langkammer C, de Graaf WL, Frederiksen JL, Larsson HB, Yiannakas M, Wheeler-Kingshott CA, Enzinger C, Khalil M, Rocca MA, Sprenger T, Amann M, Kappos L, ... ... Barkhof F, et al. Determinants of iron accumulation in deep grey matter of multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1692-8. PMID 24787429 DOI: 10.1177/1352458514531085  0.88
2014 Kilsdonk ID, Lopez-Soriano A, Kuijer JP, de Graaf WL, Castelijns JA, Polman CH, Luijten PR, Geurts JJ, Barkhof F, Wattjes MP. Morphological features of MS lesions on FLAIR* at 7 T and their relation to patient characteristics. Journal of Neurology. 261: 1356-64. PMID 24777693 DOI: 10.1007/s00415-014-7351-6  1
2014 Tewarie P, Hillebrand A, van Dellen E, Schoonheim MM, Barkhof F, Polman CH, Beaulieu C, Gong G, van Dijk BW, Stam CJ. Structural degree predicts functional network connectivity: a multimodal resting-state fMRI and MEG study. Neuroimage. 97: 296-307. PMID 24769185 DOI: 10.1016/j.neuroimage.2014.04.038  1
2014 Steenwijk MD, Daams M, Pouwels PJ, Balk LJ, Tewarie PK, Killestein J, Uitdehaag BM, Geurts JJ, Barkhof F, Vrenken H. What explains gray matter atrophy in long-standing multiple sclerosis? Radiology. 272: 832-42. PMID 24761837 DOI: 10.1148/radiol.14132708  1
2014 Ossenkoppele R, van der Flier WM, Verfaillie SC, Vrenken H, Versteeg A, van Schijndel RA, Sikkes SA, Twisk J, Adriaanse SM, Zwan MD, Boellaard R, Windhorst AD, Barkhof F, Scheltens P, Lammertsma AA, et al. Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions. Neurology. 82: 1768-75. PMID 24748672 DOI: 10.1212/WNL.0000000000000432  1
2014 van Golen LW, Veltman DJ, IJzerman RG, Deijen JB, Heijboer AC, Barkhof F, Drent ML, Diamant M. Effects of insulin detemir and NPH insulin on body weight and appetite-regulating brain regions in human type 1 diabetes: a randomized controlled trial. Plos One. 9: e94483. PMID 24739875 DOI: 10.1371/journal.pone.0094483  1
2014 Wattjes MP, Barkhof F. Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI. Current Opinion in Neurology. 27: 260-70. PMID 24739400 DOI: 10.1097/WCO.0000000000000099  1
2014 Tijms BM, Yeung HM, Sikkes SA, Möller C, Smits LL, Stam CJ, Scheltens P, van der Flier WM, Barkhof F. Single-subject gray matter graph properties and their relationship with cognitive impairment in early- and late-onset Alzheimer's disease. Brain Connectivity. 4: 337-46. PMID 24735020 DOI: 10.1089/brain.2013.0209  0.88
2014 Wattjes MP, Vennegoor A, Mostert J, van Oosten BW, Barkhof F, Killestein J. Diagnosis of asymptomatic natalizumab-associated PML: are we between a rock and a hard place? Journal of Neurology. 261: 1139-43. PMID 24705790 DOI: 10.1007/s00415-014-7336-5  0.88
2014 Oudega ML, van Exel E, Stek ML, Wattjes MP, van der Flier WM, Comijs HC, Dols A, Scheltens P, Barkhof F, Eikelenboom P, van den Heuvel OA. The structure of the geriatric depressed brain and response to electroconvulsive therapy. Psychiatry Research. 222: 1-9. PMID 24686000 DOI: 10.1016/j.pscychresns.2014.03.002  1
2014 Barkhof F, Ciccarelli O. Daclizumab in multiple sclerosis: a high-yield extension study. The Lancet. Neurology. 13: 443-4. PMID 24656610 DOI: 10.1016/S1474-4422(14)70056-0  1
2014 Tedeschi G, Gallo A, Barkhof F. Distinctive structural and functional MRI footprint for cognitive dysfunction in pediatric MS? Neurology. 82: 1296-7. PMID 24647025 DOI: 10.1212/WNL.0000000000000320  1
2014 van Duinkerken E, Ijzerman RG, van der Zijl NJ, Barkhof F, Pouwels PJ, Schoonheim MM, Moll AC, Boerop J, Wessels AM, Klein M, Snoek FJ, Diamant M. Differential impact of subclinical carotid artery disease on cerebral structure and functioning in type 1 diabetes patients with versus those without proliferative retinopathy. Cardiovascular Diabetology. 13: 58. PMID 24620788 DOI: 10.1186/1475-2840-13-58  1
2014 Adriaanse SM, van Dijk KR, Ossenkoppele R, Reuter M, Tolboom N, Zwan MD, Yaqub M, Boellaard R, Windhorst AD, van der Flier WM, Scheltens P, Lammertsma AA, Barkhof F, van Berckel BN. The effect of amyloid pathology and glucose metabolism on cortical volume loss over time in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 41: 1190-8. PMID 24615466 DOI: 10.1007/s00259-014-2704-z  1
2014 van der Flier WM, Pijnenburg YA, Prins N, Lemstra AW, Bouwman FH, Teunissen CE, van Berckel BN, Stam CJ, Barkhof F, Visser PJ, van Egmond E, Scheltens P. Optimizing patient care and research: the Amsterdam Dementia Cohort. Journal of Alzheimer's Disease : Jad. 41: 313-27. PMID 24614907 DOI: 10.3233/JAD-132306  1
2014 Haller S, Monsch AU, Richiardi J, Barkhof F, Kressig RW, Radue EW. Head motion parameters in fMRI differ between patients with mild cognitive impairment and Alzheimer disease versus elderly control subjects. Brain Topography. 27: 801-7. PMID 24599620 DOI: 10.1007/s10548-014-0358-6  1
2014 Mitjana R, Tintoré M, Rocca MA, Auger C, Barkhof F, Filippi M, Polman C, Fazekas F, Huerga E, Montalban X, Rovira A. Diagnostic value of brain chronic black holes on T1-weighted MR images in clinically isolated syndromes. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1471-7. PMID 24576831 DOI: 10.1177/1352458514526083  0.88
2014 Popescu V, Ran NC, Barkhof F, Chard DT, Wheeler-Kingshott CA, Vrenken H. Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masks. Neuroimage. Clinical. 4: 366-73. PMID 24567908 DOI: 10.1016/j.nicl.2014.01.004  1
2014 Mulder ER, de Jong RA, Knol DL, van Schijndel RA, Cover KS, Visser PJ, Barkhof F, Vrenken H. Hippocampal volume change measurement: quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST. Neuroimage. 92: 169-81. PMID 24521851 DOI: 10.1016/j.neuroimage.2014.01.058  1
2014 Aliaga ES, Barkhof F. MRI mimics of multiple sclerosis. Handbook of Clinical Neurology. 122: 291-316. PMID 24507523 DOI: 10.1016/B978-0-444-52001-2.00012-1  1
2014 Zonneveld HI, Goos JD, Wattjes MP, Prins ND, Scheltens P, van der Flier WM, Kuijer JP, Muller M, Barkhof F. Prevalence of cortical superficial siderosis in a memory clinic population. Neurology. 82: 698-704. PMID 24477113 DOI: 10.1212/WNL.0000000000000150  0.88
2014 Ascherio A, Munger KL, White R, Köchert K, Simon KC, Polman CH, Freedman MS, Hartung HP, Miller DH, Montalbán X, Edan G, Barkhof F, Pleimes D, Radü EW, Sandbrink R, et al. Vitamin D as an early predictor of multiple sclerosis activity and progression. Jama Neurology. 71: 306-14. PMID 24445558 DOI: 10.1001/jamaneurol.2013.5993  1
2014 Freedman MS, De Stefano N, Barkhof F, Polman CH, Comi G, Uitdehaag BM, Casset-Semanaz F, Hennessy B, Lehr L, Stubinski B, Jack DL, Kappos L. Patient subgroup analyses of the treatment effect of subcutaneous interferon β-1a on development of multiple sclerosis in the randomized controlled REFLEX study. Journal of Neurology. 261: 490-9. PMID 24413638 DOI: 10.1007/s00415-013-7222-6  1
2014 Wiebenga OT, Klauser AM, Nagtegaal GJ, Schoonheim MM, Barkhof F, Geurts JJ, Pouwels PJ. Longitudinal absolute metabolite quantification of white and gray matter regions in healthy controls using proton MR spectroscopic imaging. Nmr in Biomedicine. 27: 304-11. PMID 24399803 DOI: 10.1002/nbm.3063  1
2014 Woerdeman J, van Duinkerken E, Wattjes MP, Barkhof F, Snoek FJ, Moll AC, Klein M, de Boer MP, Ijzerman RG, Serné EH, Diamant M. Proliferative retinopathy in type 1 diabetes is associated with cerebral microbleeds, which is part of generalized microangiopathy. Diabetes Care. 37: 1165-8. PMID 24319122 DOI: 10.2337/dc13-1586  1
2014 Kilsdonk ID, Wattjes MP, Lopez-Soriano A, Kuijer JP, de Jong MC, de Graaf WL, Conijn MM, Polman CH, Luijten PR, Geurts JJ, Geerlings MI, Barkhof F. Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla. European Radiology. 24: 841-9. PMID 24317461 DOI: 10.1007/s00330-013-3080-y  1
2014 De Stefano N, Comi G, Kappos L, Freedman MS, Polman CH, Uitdehaag BM, Hennessy B, Casset-Semanaz F, Lehr L, Stubinski B, Jack DL, Barkhof F. Efficacy of subcutaneous interferon β-1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes. Journal of Neurology, Neurosurgery, and Psychiatry. 85: 647-53. PMID 24292999 DOI: 10.1136/jnnp-2013-306289  1
2014 Edan G, Kappos L, Montalbán X, Polman CH, Freedman MS, Hartung HP, Miller D, Barkhof F, Herrmann J, Lanius V, Stemper B, Pohl C, Sandbrink R, Pleimes D. Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT. Journal of Neurology, Neurosurgery, and Psychiatry. 85: 1183-9. PMID 24218527 DOI: 10.1136/jnnp-2013-306222  0.8
2014 van Golen LW, Kuijer JP, Huisman MC, IJzerman RG, Barkhof F, Diamant M, Lammertsma AA. Quantification of cerebral blood flow in healthy volunteers and type 1 diabetic patients: comparison of MRI arterial spin labeling and [(15)O]H2O positron emission tomography (PET). Journal of Magnetic Resonance Imaging : Jmri. 40: 1300-9. PMID 24214919 DOI: 10.1002/jmri.24484  1
2014 Smits LL, Tijms BM, Benedictus MR, Koedam EL, Koene T, Reuling IE, Barkhof F, Scheltens P, Pijnenburg YA, Wattjes MP, van der Flier WM. Regional atrophy is associated with impairment in distinct cognitive domains in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: S299-305. PMID 24210526 DOI: 10.1016/j.jalz.2013.06.007  1
2014 Tewarie P, Hillebrand A, Schoonheim MM, van Dijk BW, Geurts JJ, Barkhof F, Polman CH, Stam CJ. Functional brain network analysis using minimum spanning trees in Multiple Sclerosis: an MEG source-space study. Neuroimage. 88: 308-18. PMID 24161625 DOI: 10.1016/j.neuroimage.2013.10.022  1
2014 Harper L, Barkhof F, Scheltens P, Schott JM, Fox NC. An algorithmic approach to structural imaging in dementia. Journal of Neurology, Neurosurgery, and Psychiatry. 85: 692-8. PMID 24133287 DOI: 10.1136/jnnp-2013-306285  1
2014 Möller C, van der Flier WM, Versteeg A, Benedictus MR, Wattjes MP, Koedam EL, Scheltens P, Barkhof F, Vrenken H. Quantitative regional validation of the visual rating scale for posterior cortical atrophy. European Radiology. 24: 397-404. PMID 24092044 DOI: 10.1007/s00330-013-3025-5  1
2014 Binnewijzend MA, Adriaanse SM, Van der Flier WM, Teunissen CE, de Munck JC, Stam CJ, Scheltens P, van Berckel BN, Barkhof F, Wink AM. Brain network alterations in Alzheimer's disease measured by eigenvector centrality in fMRI are related to cognition and CSF biomarkers. Human Brain Mapping. 35: 2383-93. PMID 24039033 DOI: 10.1002/hbm.22335  1
2014 van Rooden S, Goos JD, van Opstal AM, Versluis MJ, Webb AG, Blauw GJ, van der Flier WM, Scheltens P, Barkhof F, van Buchem MA, van der Grond J. Increased number of microinfarcts in Alzheimer disease at 7-T MR imaging. Radiology. 270: 205-11. PMID 24029643 DOI: 10.1148/radiol.13130743  1
2014 Schoonheim MM, Vigeveno RM, Rueda Lopes FC, Pouwels PJ, Polman CH, Barkhof F, Geurts JJ. Sex-specific extent and severity of white matter damage in multiple sclerosis: implications for cognitive decline. Human Brain Mapping. 35: 2348-58. PMID 23982918 DOI: 10.1002/hbm.22332  1
2014 van de Kraats C, Killestein J, Popescu V, Rijkers E, Vrenken H, Lütjohann D, Barkhof F, Polman CH, Teunissen CE. Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 412-7. PMID 23959711 DOI: 10.1177/1352458513499421  1
2014 Nagtegaal GJ, Pohl C, Wattjes MP, Hulst HE, Freedman MS, Hartung HP, Miller D, Montalban X, Kappos L, Edan G, Pleimes D, Beckman K, Stemper B, Polman CH, Sandbrink R, ... Barkhof F, et al. Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 234-42. PMID 23842212 DOI: 10.1177/1352458513494491  1
2014 Kearney H, Rocca MA, Valsasina P, Balk L, Sastre-Garriga J, Reinhardt J, Ruggieri S, Rovira A, Stippich C, Kappos L, Sprenger T, Tortorella P, Rovaris M, Gasperini C, Montalban X, ... ... Barkhof F, et al. Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 72-80. PMID 23812283 DOI: 10.1177/1352458513492245  1
2014 Krudop WA, Kerssens CJ, Dols A, Prins ND, Möller C, Schouws S, Barkhof F, van Berckel BN, Teunissen CE, van der Flier WM, Scheltens P, Stek ML, Pijnenburg YA. Building a new paradigm for the early recognition of behavioral variant frontotemporal dementia: Late Onset Frontal Lobe Syndrome study. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 22: 735-40. PMID 23806681 DOI: 10.1016/j.jagp.2013.02.002  1
2014 Hofstetter L, Naegelin Y, Filli L, Kuster P, Traud S, Smieskova R, Mueller-Lenke N, Kappos L, Gass A, Sprenger T, Penner IK, Nichols TE, Vrenken H, Barkhof F, Polman C, et al. Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 202-13. PMID 23804554 DOI: 10.1177/1352458513493034  1
2014 Ropele S, Wattjes MP, Langkammer C, Kilsdonk ID, Graaf WL, Frederiksen JL, Fuglø D, Yiannakas M, Wheeler-Kingshott CA, Enzinger C, Rocca MA, Sprenger T, Amman M, Kappos L, Filippi M, ... ... Barkhof F, et al. Multicenter R2* mapping in the healthy brain. Magnetic Resonance in Medicine. 71: 1103-7. PMID 23657963 DOI: 10.1002/mrm.24772  1
2014 Oudega ML, van Exel E, Wattjes MP, Comijs HC, Scheltens P, Barkhof F, Eikelenboom P, de Craen AJ, Beekman AT, Stek ML. White matter hyperintensities and cognitive impairment during electroconvulsive therapy in severely depressed elderly patients. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 22: 157-66. PMID 23567440 DOI: 10.1016/j.jagp.2012.08.002  1
2014 Vrenken H, Vos EK, van der Flier WM, Sluimer IC, Cover KS, Knol DL, Barkhof F. Validation of the automated method VIENA: an accurate, precise, and robust measure of ventricular enlargement. Human Brain Mapping. 35: 1101-10. PMID 23362163 DOI: 10.1002/hbm.22237  1
2014 Adriaanse SM, Sanz-Arigita EJ, Binnewijzend MA, Ossenkoppele R, Tolboom N, van Assema DM, Wink AM, Boellaard R, Yaqub M, Windhorst AD, van der Flier WM, Scheltens P, Lammertsma AA, Rombouts SA, Barkhof F, et al. Amyloid and its association with default network integrity in Alzheimer's disease. Human Brain Mapping. 35: 779-91. PMID 23238869 DOI: 10.1002/hbm.22213  1
2014 Barkhof F. Introduction to "Quantitative MRI of the Spinal Cord" Quantitative Mri of the Spinal Cord. xvii-xvii. DOI: 10.1016/B978-0-12-396973-6.06001-9  1
2013 Schoonheim M, Geurts J, Wiebenga O, De Munck J, Polman C, Stam C, Barkhof F, Wink A. Changes in functional network centrality underlie cognitive dysfunction and physical disability in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1058-1065. PMID 24347184 DOI: 10.1177/1352458513516892  1
2013 Hulst HE, Gehring K, Uitdehaag BM, Visser LH, Polman CH, Barkhof F, Sitskoorn MM, Geurts JJ. Indicators for cognitive performance and subjective cognitive complaints in multiple sclerosis: a role for advanced MRI? Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1131-1134. PMID 24277326 DOI: 10.1177/1352458513513969  1
2013 Steenwijk MD, Pouwels PJ, Daams M, van Dalen JW, Caan MW, Richard E, Barkhof F, Vrenken H. Accurate white matter lesion segmentation by k nearest neighbor classification with tissue type priors (kNN-TTPs). Neuroimage. Clinical. 3: 462-9. PMID 24273728 DOI: 10.1016/j.nicl.2013.10.003  1
2013 Barkhof F, Wattjes MP. Multiple sclerosis: CCSVI deconstructed and discarded. Nature Reviews. Neurology. 9: 661-2. PMID 24217512 DOI: 10.1038/nrneurol.2013.228  1
2013 Wattjes MP, Richert ND, Killestein J, de Vos M, Sanchez E, Snaebjornsson P, Cadavid D, Barkhof F. The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1826-40. PMID 24192217 DOI: 10.1177/1352458513510224  1
2013 Van der Meer ML, Tewarie P, Schoonheim MM, Douw L, Barkhof F, Polman CH, Stam CJ, Hillebrand A. Cognition in MS correlates with resting-state oscillatory brain activity: An explorative MEG source-space study. Neuroimage. Clinical. 2: 727-34. PMID 24179824 DOI: 10.1016/j.nicl.2013.05.003  1
2013 Tanskanen M, Kalaria RN, Notkola IL, Mäkelä M, Polvikoski T, Myllykangas L, Sulkava R, Kalimo H, Paetau A, Scheltens P, Barkhof F, van Straaten E, Erkinjuntti T. Relationships between white matter hyperintensities, cerebral amyloid angiopathy and dementia in a population-based sample of the oldest old. Current Alzheimer Research. 10: 1090-7. PMID 24156259  1
2013 De Witt Hamer PC, Hendriks EJ, Mandonnet E, Barkhof F, Zwinderman AH, Duffau H. Resection probability maps for quality assessment of glioma surgery without brain location bias. Plos One. 8: e73353. PMID 24039922 DOI: 10.1371/journal.pone.0073353  1
2013 Schuitema I, Deprez S, Van Hecke W, Daams M, Uyttebroeck A, Sunaert S, Barkhof F, van Dulmen-den Broeder E, van der Pal HJ, van den Bos C, Veerman AJ, de Sonneville LM. Accelerated aging, decreased white matter integrity, and associated neuropsychological dysfunction 25 years after pediatric lymphoid malignancies. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 3378-88. PMID 23960182 DOI: 10.1200/JCO.2012.46.7050  1
2013 Tewarie P, Schoonheim MM, Stam CJ, van der Meer ML, van Dijk BW, Barkhof F, Polman CH, Hillebrand A. Cognitive and clinical dysfunction, altered MEG resting-state networks and thalamic atrophy in multiple sclerosis. Plos One. 8: e69318. PMID 23935983 DOI: 10.1371/journal.pone.0069318  1
2013 Frisoni GB, Bocchetta M, Chételat G, Rabinovici GD, de Leon MJ, Kaye J, Reiman EM, Scheltens P, Barkhof F, Black SE, Brooks DJ, Carrillo MC, Fox NC, Herholz K, Nordberg A, et al. Imaging markers for Alzheimer disease: which vs how. Neurology. 81: 487-500. PMID 23897875 DOI: 10.1212/WNL.0b013e31829d86e8  1
2013 Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O'Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. The Lancet. Neurology. 12: 822-38. PMID 23867200 DOI: 10.1016/S1474-4422(13)70124-8  1
2013 Daams M, Geurts JJ, Barkhof F. Cortical imaging in multiple sclerosis: recent findings and 'grand challenges'. Current Opinion in Neurology. 26: 345-52. PMID 23812306 DOI: 10.1097/WCO.0b013e328362a864  1
2013 Barkhof F. Efficient use of MRI for dose finding in multiple sclerosis. The Lancet. Neurology. 12: 730-1. PMID 23768777 DOI: 10.1016/S1474-4422(13)70127-3  1
2013 Lukas C, Sombekke MH, Bellenberg B, Hahn HK, Popescu V, Bendfeldt K, Radue EW, Gass A, Borgwardt SJ, Kappos L, Naegelin Y, Knol DL, Polman CH, Geurts JJ, Barkhof F, et al. Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patients. Radiology. 269: 542-52. PMID 23737540 DOI: 10.1148/radiol.13122566  1
2013 Benedictus MR, Goos JD, Binnewijzend MA, Muller M, Barkhof F, Scheltens P, Prins ND, van der Flier WM. Specific risk factors for microbleeds and white matter hyperintensities in Alzheimer's disease. Neurobiology of Aging. 34: 2488-94. PMID 23731952 DOI: 10.1016/j.neurobiolaging.2013.04.023  1
2013 Wattjes MP, Verhoeff L, Zentjens W, Killestein J, van Munster ET, Barkhof F, van Eijk JJ. Punctate lesion pattern suggestive of perivascular inflammation in acute natalizumab-associated progressive multifocal leukoencephalopathy: productive JC virus infection or preclinical PML-IRIS manifestation? Journal of Neurology, Neurosurgery, and Psychiatry. 84: 1176-7. PMID 23695498 DOI: 10.1136/jnnp-2013-304986  1
2013 Cohen JA, Barkhof F, Comi G, Izquierdo G, Khatri B, Montalban X, Pelletier J, Eckert B, Häring DA, Francis G. Fingolimod versus intramuscular interferon in patient subgroups from TRANSFORMS. Journal of Neurology. 260: 2023-32. PMID 23632946 DOI: 10.1007/s00415-013-6932-0  1
2013 Wallner-Blazek M, Rovira A, Fillipp M, Rocca MA, Miller DH, Schmierer K, Frederiksen J, Gass A, Gama H, Tilbery CP, Rocha AJ, Flores J, Barkhof F, Seewann A, Palace J, et al. Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis. Journal of Neurology. 260: 2016-22. PMID 23620065 DOI: 10.1007/s00415-013-6918-y  1
2013 van Oosten BW, Killestein J, Barkhof F, Polman CH, Wattjes MP. PML in a patient treated with dimethyl fumarate from a compounding pharmacy. The New England Journal of Medicine. 368: 1658-9. PMID 23614604 DOI: 10.1056/NEJMc1215357  1
2013 van Egmond ME, Pouwels PJ, Boelens JJ, Lindemans CA, Barkhof F, Steenwijk MD, van Hasselt PM, van der Knaap MS, Wolf NI. Improvement of white matter changes on neuroimaging modalities after stem cell transplant in metachromatic leukodystrophy. Jama Neurology. 70: 779-82. PMID 23608771 DOI: 10.1001/jamaneurol.2013.629  1
2013 Harlaar L, Pouwels PJ, Geytenbeek J, Oostrom K, Barkhof F, Vermeulen RJ. Language comprehension in young people with severe cerebral palsy in relation to language tracts: a diffusion tensor imaging study. Neuropediatrics. 44: 286-90. PMID 23564318 DOI: 10.1055/s-0033-1341600  1
2013 Prins ND, van der Flier WM, Brashear HR, Knol DL, van de Pol LA, Barkhof F, Scheltens P. Predictors of progression from mild cognitive impairment to dementia in the placebo-arm of a clinical trial population. Journal of Alzheimer's Disease : Jad. 36: 79-85. PMID 23563246 DOI: 10.3233/JAD-122233  1
2013 Möller C, Vrenken H, Jiskoot L, Versteeg A, Barkhof F, Scheltens P, van der Flier WM. Different patterns of gray matter atrophy in early- and late-onset Alzheimer's disease. Neurobiology of Aging. 34: 2014-22. PMID 23561509 DOI: 10.1016/j.neurobiolaging.2013.02.013  1
2013 Tijms BM, Wink AM, de Haan W, van der Flier WM, Stam CJ, Scheltens P, Barkhof F. Alzheimer's disease: connecting findings from graph theoretical studies of brain networks. Neurobiology of Aging. 34: 2023-36. PMID 23541878 DOI: 10.1016/j.neurobiolaging.2013.02.020  1
2013 Clerx L, van Rossum IA, Burns L, Knol DL, Scheltens P, Verhey F, Aalten P, Lapuerta P, van de Pol L, van Schijndel R, de Jong R, Barkhof F, Wolz R, Rueckert D, Bocchetta M, et al. Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment. Neurobiology of Aging. 34: 2003-13. PMID 23540941 DOI: 10.1016/j.neurobiolaging.2013.02.002  1
2013 Tijms BM, Möller C, Vrenken H, Wink AM, de Haan W, van der Flier WM, Stam CJ, Scheltens P, Barkhof F. Single-subject grey matter graphs in Alzheimer's disease. Plos One. 8: e58921. PMID 23536835 DOI: 10.1371/journal.pone.0058921  1
2013 Popescu V, Agosta F, Hulst HE, Sluimer IC, Knol DL, Sormani MP, Enzinger C, Ropele S, Alonso J, Sastre-Garriga J, Rovira A, Montalban X, Bodini B, Ciccarelli O, Khaleeli Z, ... ... Barkhof F, et al. Brain atrophy and lesion load predict long term disability in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 1082-91. PMID 23524331 DOI: 10.1136/jnnp-2012-304094  1
2013 Hulst HE, Steenwijk MD, Versteeg A, Pouwels PJ, Vrenken H, Uitdehaag BM, Polman CH, Geurts JJ, Barkhof F. Cognitive impairment in MS: impact of white matter integrity, gray matter volume, and lesions. Neurology. 80: 1025-32. PMID 23468546 DOI: 10.1212/WNL.0b013e31828726cc  1
2013 Barkhof F, Daams M, Scheltens P, Brashear HR, Arrighi HM, Bechten A, Morris K, McGovern M, Wattjes MP. An MRI rating scale for amyloid-related imaging abnormalities with edema or effusion. Ajnr. American Journal of Neuroradiology. 34: 1550-5. PMID 23436056 DOI: 10.3174/ajnr.A3475  0.88
2013 Jokinen H, Schmidt R, Ropele S, Fazekas F, Gouw AA, Barkhof F, Scheltens P, Madureira S, Verdelho A, Ferro JM, Wallin A, Poggesi A, Inzitari D, Pantoni L, Erkinjuntti T, et al. Diffusion changes predict cognitive and functional outcome: the LADIS study. Annals of Neurology. 73: 576-83. PMID 23423951 DOI: 10.1002/ana.23802  1
2013 Grooters GS, Visser LH, Barkhof F, van der Knaap MS, van Asseldonk JT. Mystery case: Baló concentric sclerosis. Neurology. 80: e71-2; discussion e7. PMID 23400322 DOI: 10.1212/WNL.0b013e3182824e7d  0.84
2013 Prestia A, Caroli A, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall AE, Carter SF, Schöll M, Choo IH, Nordberg A, Scheltens P, Frisoni GB. Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease. Neurology. 80: 1048-56. PMID 23390179 DOI: 10.1212/WNL.0b013e3182872830  1
2013 Dodel R, Rominger A, Bartenstein P, Barkhof F, Blennow K, Förster S, Winter Y, Bach JP, Popp J, Alferink J, Wiltfang J, Buerger K, Otto M, Antuono P, Jacoby M, et al. Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial. The Lancet. Neurology. 12: 233-43. PMID 23375965 DOI: 10.1016/S1474-4422(13)70014-0  1
2013 van der Vlies AE, Staekenborg SS, Admiraal-Behloul F, Prins ND, Barkhof F, Vrenken H, Reiber JH, Scheltens P, van der Flier WM. Associations between magnetic resonance imaging measures and neuropsychological impairment in early and late onset alzheimer's disease. Journal of Alzheimer's Disease : Jad. 35: 169-78. PMID 23364136 DOI: 10.3233/JAD-121291  1
2013 Vrenken H, Jenkinson M, Horsfield MA, Battaglini M, van Schijndel RA, Rostrup E, Geurts JJ, Fisher E, Zijdenbos A, Ashburner J, Miller DH, Filippi M, Fazekas F, Rovaris M, Rovira A, ... Barkhof F, et al. Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis. Journal of Neurology. 260: 2458-71. PMID 23263472 DOI: 10.1007/s00415-012-6762-5  1
2013 Ossenkoppele R, van der Flier WM, Zwan MD, Adriaanse SF, Boellaard R, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van Berckel BN. Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia. Neurology. 80: 359-65. PMID 23255822 DOI: 10.1212/WNL.0b013e31827f0889  1
2013 Sombekke MH, Wattjes MP, Balk LJ, Nielsen JM, Vrenken H, Uitdehaag BM, Polman CH, Barkhof F. Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis. Neurology. 80: 69-75. PMID 23243070 DOI: 10.1212/WNL.0b013e31827b1a67  1
2013 Binnewijzend MA, Kuijer JP, Benedictus MR, van der Flier WM, Wink AM, Wattjes MP, van Berckel BN, Scheltens P, Barkhof F. Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity. Radiology. 267: 221-30. PMID 23238159 DOI: 10.1148/radiol.12120928  1
2013 Giorgio A, Battaglini M, Rocca MA, De Leucio A, Absinta M, van Schijndel R, Rovira A, Tintoré M, Chard D, Ciccarelli O, Enzinger C, Gasperini C, Frederiksen J, Filippi M, Barkhof F, et al. Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis. Neurology. 80: 234-41. PMID 23223533 DOI: 10.1212/WNL.0b013e31827debeb  1
2013 Zarei M, Beckmann CF, Binnewijzend MA, Schoonheim MM, Oghabian MA, Sanz-Arigita EJ, Scheltens P, Matthews PM, Barkhof F. Functional segmentation of the hippocampus in the healthy human brain and in Alzheimer's disease. Neuroimage. 66: 28-35. PMID 23128076 DOI: 10.1016/j.neuroimage.2012.10.071  1
2013 Kilsdonk ID, de Graaf WL, Soriano AL, Zwanenburg JJ, Visser F, Kuijer JP, Geurts JJ, Pouwels PJ, Polman CH, Castelijns JA, Luijten PR, Barkhof F, Wattjes MP. Multicontrast MR imaging at 7T in multiple sclerosis: highest lesion detection in cortical gray matter with 3D-FLAIR. Ajnr. American Journal of Neuroradiology. 34: 791-6. PMID 23042930 DOI: 10.3174/ajnr.A3289  1
2013 Vennegoor A, Rispens T, Strijbis EM, Seewann A, Uitdehaag BM, Balk LJ, Barkhof F, Polman CH, Wolbink G, Killestein J. Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 593-600. PMID 22992450 DOI: 10.1177/1352458512460604  1
2013 de Graaf WL, Kilsdonk ID, Lopez-Soriano A, Zwanenburg JJ, Visser F, Polman CH, Castelijns JA, Geurts JJ, Pouwels PJ, Luijten PR, Barkhof F, Wattjes MP. Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: increased lesion detection compared to 3 T confined to grey matter. European Radiology. 23: 528-40. PMID 22898935 DOI: 10.1007/s00330-012-2619-7  1
2013 Inkster B, Strijbis EM, Vounou M, Kappos L, Radue EW, Matthews PM, Uitdehaag BM, Barkhof F, Polman CH, Montana G, Geurts JJ. Histone deacetylase gene variants predict brain volume changes in multiple sclerosis. Neurobiology of Aging. 34: 238-47. PMID 22884548 DOI: 10.1016/j.neurobiolaging.2012.07.007  1
2013 Strijbis EM, Inkster B, Vounou M, Naegelin Y, Kappos L, Radue EW, Matthews PM, Uitdehaag BM, Barkhof F, Polman CH, Montana G, Geurts JJ. Glutamate gene polymorphisms predict brain volumes in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 281-8. PMID 22851457 DOI: 10.1177/1352458512454345  1
2013 Schuitemaker A, Kropholler MA, Boellaard R, van der Flier WM, Kloet RW, van der Doef TF, Knol DL, Windhorst AD, Luurtsema G, Barkhof F, Jonker C, Lammertsma AA, Scheltens P, van Berckel BN. Microglial activation in Alzheimer's disease: an (R)-[¹¹C]PK11195 positron emission tomography study. Neurobiology of Aging. 34: 128-36. PMID 22840559 DOI: 10.1016/j.neurobiolaging.2012.04.021  1
2013 Lehmann M, Koedam EL, Barnes J, Bartlett JW, Barkhof F, Wattjes MP, Schott JM, Scheltens P, Fox NC. Visual ratings of atrophy in MCI: prediction of conversion and relationship with CSF biomarkers. Neurobiology of Aging. 34: 73-82. PMID 22516280 DOI: 10.1016/j.neurobiolaging.2012.03.010  1
2013 Schoonheim MM, Geurts JJ, Landi D, Douw L, van der Meer ML, Vrenken H, Polman CH, Barkhof F, Stam CJ. Functional connectivity changes in multiple sclerosis patients: a graph analytical study of MEG resting state data. Human Brain Mapping. 34: 52-61. PMID 21954106 DOI: 10.1002/hbm.21424  1
2013 Zarei M, Beckmann CF, Binnewijzend MAA, Schoonheim MM, Oghabian MA, Sanz-Arigita EJ, Scheltens P, Matthews PM, Barkhof F. Corrigendum to "Functional segmentation of the hippocampus in the healthy human brain and in Alzheimer's disease" [Neuroimage 66 (2013) 28-35] Neuroimage. 83: 1109. DOI: 10.1016/j.neuroimage.2013.09.005  1
2012 Schoonheim MM, Popescu V, Rueda Lopes FC, Wiebenga OT, Vrenken H, Douw L, Polman CH, Geurts JJ, Barkhof F. Subcortical atrophy and cognition: sex effects in multiple sclerosis. Neurology. 79: 1754-61. PMID 23019265 DOI: 10.1212/WNL.0b013e3182703f46  1
2012 van Rossum IA, Vos SJ, Burns L, Knol DL, Scheltens P, Soininen H, Wahlund LO, Hampel H, Tsolaki M, Minthon L, L'italien G, van der Flier WM, Teunissen CE, Blennow K, Barkhof F, et al. Injury markers predict time to dementia in subjects with MCI and amyloid pathology. Neurology. 79: 1809-16. PMID 23019259 DOI: 10.1212/WNL.0b013e3182704056  1
2012 Wink AM, de Munck JC, van der Werf YD, van den Heuvel OA, Barkhof F. Fast eigenvector centrality mapping of voxel-wise connectivity in functional magnetic resonance imaging: implementation, validation, and interpretation. Brain Connectivity. 2: 265-74. PMID 23016836 DOI: 10.1089/brain.2012.0087  0.76
2012 Schaafsma JD, Velthuis BK, van den Berg R, Brouwer PA, Majoie CB, Barkhof F, Eshghi O, de Kort GA, Lo RT, Sprengers ME, van Rooij WJ, Bot JC, Rinkel GJ. Coil-treated aneurysms: decision making regarding additional treatment based on findings of MR angiography and intraarterial DSA. Radiology. 265: 858-63. PMID 23012464 DOI: 10.1148/radiol.12112608  1
2012 Tomassini V, Matthews PM, Thompson AJ, Fuglø D, Geurts JJ, Johansen-Berg H, Jones DK, Rocca MA, Wise RG, Barkhof F, Palace J. Neuroplasticity and functional recovery in multiple sclerosis. Nature Reviews. Neurology. 8: 635-46. PMID 22986429 DOI: 10.1038/nrneurol.2012.179  1
2012 Pleizier CM, van der Vlies AE, Koedam E, Koene T, Barkhof F, van der Flier WM, Scheltens P, Pijnenburg Y. Episodic memory and the medial temporal lobe: not all it seems. Evidence from the temporal variants of frontotemporal dementia. Journal of Neurology, Neurosurgery, and Psychiatry. 83: 1145-8. PMID 22933816 DOI: 10.1136/jnnp-2012-302437  1
2012 Filippi M, Agosta F, Barkhof F, Dubois B, Fox NC, Frisoni GB, Jack CR, Johannsen P, Miller BL, Nestor PJ, Scheltens P, Sorbi S, Teipel S, Thompson PM, Wahlund LO, et al. EFNS task force: the use of neuroimaging in the diagnosis of dementia. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 19: e131-40, 1487-501. PMID 22900895 DOI: 10.1111/j.1468-1331.2012.03859.x  1
2012 Schmidt R, Berghold A, Jokinen H, Gouw AA, van der Flier WM, Barkhof F, Scheltens P, Petrovic K, Madureira S, Verdelho A, Ferro JM, Waldemar G, Wallin A, Wahlund LO, Poggesi A, et al. White matter lesion progression in LADIS: frequency, clinical effects, and sample size calculations. Stroke; a Journal of Cerebral Circulation. 43: 2643-7. PMID 22879094 DOI: 10.1161/STROKEAHA.112.662593  1
2012 van der Vlies AE, Goos JD, Barkhof F, Scheltens P, van der Flier WM. Microbleeds do not affect rate of cognitive decline in Alzheimer disease. Neurology. 79: 763-9. PMID 22875093 DOI: 10.1212/WNL.0b013e3182661f91  1
2012 Hardmeier M, Schoonheim MM, Geurts JJ, Hillebrand A, Polman CH, Barkhof F, Stam CJ. Cognitive dysfunction in early multiple sclerosis: altered centrality derived from resting-state functional connectivity using magneto-encephalography. Plos One. 7: e42087. PMID 22848712 DOI: 10.1371/journal.pone.0042087  1
2012 van Straaten EC, de Haan W, de Waal H, Scheltens P, van der Flier WM, Barkhof F, Koene T, Stam CJ. Disturbed oscillatory brain dynamics in subcortical ischemic vascular dementia. Bmc Neuroscience. 13: 85. PMID 22827860 DOI: 10.1186/1471-2202-13-85  0.88
2012 Wattjes MP, Barkhof F. Diagnostic relevance of high field MRI in clinical neuroradiology: the advantages and challenges of driving a sports car. European Radiology. 22: 2304-6. PMID 22821393 DOI: 10.1007/s00330-012-2552-9  0.84
2012 Vigeveno RM, Wiebenga OT, Wattjes MP, Geurts JJ, Barkhof F. Shifting imaging targets in multiple sclerosis: from inflammation to neurodegeneration. Journal of Magnetic Resonance Imaging : Jmri. 36: 1-19. PMID 22696123 DOI: 10.1002/jmri.23578  1
2012 Teunissen CE, Sombekke M, van Winsen L, Killestein J, Barkhof F, Polman CH, Dijkstra CD, Blankenstein MA, Pratico D. Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 1092-8. PMID 22695538 DOI: 10.1177/1352458511433306  1
2012 Jokinen H, Lipsanen J, Schmidt R, Fazekas F, Gouw AA, van der Flier WM, Barkhof F, Madureira S, Verdelho A, Ferro JM, Wallin A, Pantoni L, Inzitari D, Erkinjuntti T. Brain atrophy accelerates cognitive decline in cerebral small vessel disease: the LADIS study. Neurology. 78: 1785-92. PMID 22592361 DOI: 10.1212/WNL.0b013e3182583070  1
2012 Ossenkoppele R, Zwan MD, Tolboom N, van Assema DM, Adriaanse SF, Kloet RW, Boellaard R, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement. Brain : a Journal of Neurology. 135: 2115-25. PMID 22556189 DOI: 10.1093/brain/aws113  1
2012 Kilsdonk ID, de Graaf WL, Barkhof F, Wattjes MP. Inflammation high-field magnetic resonance imaging. Neuroimaging Clinics of North America. 22: 135-57, ix. PMID 22548925 DOI: 10.1016/j.nic.2012.02.010  0.84
2012 Jokinen H, Frederiksen KS, Garde E, Skimminge A, Siebner H, Waldemar G, Ylikoski R, Madureira S, Verdelho A, van Straaten EC, Barkhof F, Fazekas F, Schmidt R, Pantoni L, Inzitari D, et al. Callosal tissue loss parallels subtle decline in psychomotor speed. a longitudinal quantitative MRI study. The LADIS Study. Neuropsychologia. 50: 1650-5. PMID 22497753 DOI: 10.1016/j.neuropsychologia.2012.03.020  0.48
2012 Filli L, Hofstetter L, Kuster P, Traud S, Mueller-Lenke N, Naegelin Y, Kappos L, Gass A, Sprenger T, Nichols TE, Vrenken H, Barkhof F, Polman C, Radue EW, Borgwardt SJ, et al. Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 1577-84. PMID 22495945 DOI: 10.1177/1352458512442756  1
2012 Penner IK, Stemper B, Calabrese P, Freedman MS, Polman CH, Edan G, Hartung HP, Miller DH, Montalbán X, Barkhof F, Pleimes D, Lanius V, Pohl C, Kappos L, Sandbrink R. Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 1466-71. PMID 22492127 DOI: 10.1177/1352458512442438  1
2012 Popescu V, Battaglini M, Hoogstrate WS, Verfaillie SC, Sluimer IC, van Schijndel RA, van Dijk BW, Cover KS, Knol DL, Jenkinson M, Barkhof F, de Stefano N, Vrenken H. Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1 images in multiple sclerosis. Neuroimage. 61: 1484-94. PMID 22484407 DOI: 10.1016/j.neuroimage.2012.03.074  1
2012 Ossenkoppele R, Tolboom N, Foster-Dingley JC, Adriaanse SF, Boellaard R, Yaqub M, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN. Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET. European Journal of Nuclear Medicine and Molecular Imaging. 39: 990-1000. PMID 22441582 DOI: 10.1007/s00259-012-2102-3  1
2012 Filippi M, Rocca MA, Barkhof F, Brück W, Chen JT, Comi G, DeLuca G, De Stefano N, Erickson BJ, Evangelou N, Fazekas F, Geurts JJ, Lucchinetti C, Miller DH, Pelletier D, et al. Association between pathological and MRI findings in multiple sclerosis. The Lancet. Neurology. 11: 349-60. PMID 22441196 DOI: 10.1016/S1474-4422(12)70003-0  1
2012 van Duinkerken E, Schoonheim MM, Sanz-Arigita EJ, IJzerman RG, Moll AC, Snoek FJ, Ryan CM, Klein M, Diamant M, Barkhof F. Resting-state brain networks in type 1 diabetic patients with and without microangiopathy and their relation to cognitive functions and disease variables. Diabetes. 61: 1814-21. PMID 22438575 DOI: 10.2337/db11-1358  0.84
2012 van der Lei HD, Steenweg ME, Barkhof F, de Grauw T, d'Hooghe M, Morton R, Shah S, Wolf N, van der Knaap MS. Characteristics of early MRI in children and adolescents with vanishing white matter. Neuropediatrics. 43: 22-6. PMID 22430157 DOI: 10.1055/s-0032-1307456  1
2012 Grimaldi L, Barkhof F, Beelke M, Burton J, Holmoy T, Hupperts R, Killestein J, Rieckmann P, Schluep M, Smolders J. A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis. Neurology. 78: 841. PMID 22411961 DOI: 10.1212/01.wnl.0000413180.13413.ce  0.84
2012 van Duinkerken E, Schoonheim MM, Ijzerman RG, Klein M, Ryan CM, Moll AC, Snoek FJ, Barkhof F, Diamant M, Pouwels PJ. Diffusion tensor imaging in type 1 diabetes: decreased white matter integrity relates to cognitive functions. Diabetologia. 55: 1218-20. PMID 22327286 DOI: 10.1007/s00125-012-2488-2  0.84
2012 Steenweg ME, Vanderver A, Ceulemans B, Prabhakar P, Régal L, Fattal-Valevski A, Richer L, Simonetti BG, Barkhof F, Rodenburg RJ, Pouwels PJ, van der Knaap MS. Novel infantile-onset leukoencephalopathy with high lactate level and slow improvement. Archives of Neurology. 69: 718-22. PMID 22312165 DOI: 10.1001/archneurol.2011.1048  1
2012 van der Lei HD, Steenweg ME, Bugiani M, Pouwels PJ, Vent IM, Barkhof F, van Wieringen WN, van der Knaap MS. Restricted diffusion in vanishing white matter. Archives of Neurology. 69: 723-7. PMID 22312162 DOI: 10.1001/archneurol.2011.1658  1
2012 Rostrup E, Gouw AA, Vrenken H, van Straaten EC, Ropele S, Pantoni L, Inzitari D, Barkhof F, Waldemar G. The spatial distribution of age-related white matter changes as a function of vascular risk factors--results from the LADIS study. Neuroimage. 60: 1597-607. PMID 22305990 DOI: 10.1016/j.neuroimage.2012.01.106  1
2012 Wilkinson D, Fox NC, Barkhof F, Phul R, Lemming O, Scheltens P. Memantine and brain atrophy in Alzheimer's disease: a 1-year randomized controlled trial. Journal of Alzheimer's Disease : Jad. 29: 459-69. PMID 22269160 DOI: 10.3233/JAD-2011-111616  1
2012 Vos S, van Rossum I, Burns L, Knol D, Scheltens P, Soininen H, Wahlund LO, Hampel H, Tsolaki M, Minthon L, Handels R, L'Italien G, van der Flier W, Aalten P, Teunissen C, ... Barkhof F, et al. Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI. Neurobiology of Aging. 33: 2272-81. PMID 22264648 DOI: 10.1016/j.neurobiolaging.2011.12.017  1
2012 van Rossum IA, Visser PJ, Knol DL, van der Flier WM, Teunissen CE, Barkhof F, Blankenstein MA, Scheltens P. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 29: 319-27. PMID 22233766 DOI: 10.3233/JAD-2011-111694  1
2012 Steenweg ME, Wolf NI, Schieving JH, Fawzi Elsaid M, Friederich RL, Ostergaard JR, Barkhof F, Pouwels PJ, van der Knaap MS. Novel hypomyelinating leukoencephalopathy affecting early myelinating structures. Archives of Neurology. 69: 125-8. PMID 22232354 DOI: 10.1001/archneurol.2011.1030  1
2012 Seewann A, Kooi EJ, Roosendaal SD, Pouwels PJ, Wattjes MP, van der Valk P, Barkhof F, Polman CH, Geurts JJ. Postmortem verification of MS cortical lesion detection with 3D DIR. Neurology. 78: 302-8. PMID 22218278 DOI: 10.1212/WNL.0b013e31824528a0  1
2012 Comi G, De Stefano N, Freedman MS, Barkhof F, Polman CH, Uitdehaag BM, Casset-Semanaz F, Hennessy B, Moraga MS, Rocak S, Stubinski B, Kappos L. Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial. The Lancet. Neurology. 11: 33-41. PMID 22146409 DOI: 10.1016/S1474-4422(11)70262-9  1
2012 Barkhof F, Simon JH, Fazekas F, Rovaris M, Kappos L, de Stefano N, Polman CH, Petkau J, Radue EW, Sormani MP, Li DK, O'Connor P, Montalban X, Miller DH, Filippi M. MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials. Nature Reviews. Neurology. 8: 13-21. PMID 22143362 DOI: 10.1038/nrneurol.2011.190  1
2012 Goos JD, Teunissen CE, Veerhuis R, Verwey NA, Barkhof F, Blankenstein MA, Scheltens P, van der Flier WM. Microbleeds relate to altered amyloid-β metabolism in Alzheimer's disease. Neurobiology of Aging. 33: 1011.e1-9. PMID 22118945 DOI: 10.1016/j.neurobiolaging.2011.10.026  1
2012 Buis DR, Bot JC, Barkhof F, Knol DL, Lagerwaard FJ, Slotman BJ, Vandertop WP, van den Berg R. The predictive value of 3D time-of-flight MR angiography in assessment of brain arteriovenous malformation obliteration after radiosurgery. Ajnr. American Journal of Neuroradiology. 33: 232-8. PMID 22095967 DOI: 10.3174/ajnr.A2744  0.88
2012 Schoonheim MM, Hulst HE, Landi D, Ciccarelli O, Roosendaal SD, Sanz-Arigita EJ, Vrenken H, Polman CH, Stam CJ, Barkhof F, Geurts JJ. Gender-related differences in functional connectivity in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 164-73. PMID 21908484 DOI: 10.1177/1352458511422245  1
2012 Hulst HE, Schoonheim MM, Roosendaal SD, Popescu V, Schweren LJ, van der Werf YD, Visser LH, Polman CH, Barkhof F, Geurts JJ. Functional adaptive changes within the hippocampal memory system of patients with multiple sclerosis. Human Brain Mapping. 33: 2268-80. PMID 21898674 DOI: 10.1002/hbm.21359  1
2012 de Graaf WL, Zwanenburg JJ, Visser F, Wattjes MP, Pouwels PJ, Geurts JJ, Polman CH, Barkhof F, Luijten PR, Castelijns JA. Lesion detection at seven Tesla in multiple sclerosis using magnetisation prepared 3D-FLAIR and 3D-DIR. European Radiology. 22: 221-31. PMID 21874361 DOI: 10.1007/s00330-011-2242-z  1
2012 Binnewijzend MA, Schoonheim MM, Sanz-Arigita E, Wink AM, van der Flier WM, Tolboom N, Adriaanse SM, Damoiseaux JS, Scheltens P, van Berckel BN, Barkhof F. Resting-state fMRI changes in Alzheimer's disease and mild cognitive impairment. Neurobiology of Aging. 33: 2018-28. PMID 21862179 DOI: 10.1016/j.neurobiolaging.2011.07.003  1
2012 Janzen J, van 't Ent D, Lemstra AW, Berendse HW, Barkhof F, Foncke EM. The pedunculopontine nucleus is related to visual hallucinations in Parkinson's disease: preliminary results of a voxel-based morphometry study. Journal of Neurology. 259: 147-54. PMID 21717194 DOI: 10.1007/s00415-011-6149-z  1
2012 Lehmann M, Koedam EL, Barnes J, Bartlett JW, Ryan NS, Pijnenburg YA, Barkhof F, Wattjes MP, Scheltens P, Fox NC. Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease. Neurobiology of Aging. 33: 627.e1-627.e12. PMID 21596458 DOI: 10.1016/j.neurobiolaging.2011.04.003  1
2012 Bendfeldt K, Hofstetter L, Kuster P, Traud S, Mueller-Lenke N, Naegelin Y, Kappos L, Gass A, Nichols TE, Barkhof F, Vrenken H, Roosendaal SD, Geurts JJ, Radue EW, Borgwardt SJ. Longitudinal gray matter changes in multiple sclerosis--differential scanner and overall disease-related effects. Human Brain Mapping. 33: 1225-45. PMID 21538703 DOI: 10.1002/hbm.21279  1
2012 de Bie HM, Boersma M, Adriaanse S, Veltman DJ, Wink AM, Roosendaal SD, Barkhof F, Stam CJ, Oostrom KJ, Delemarre-van de Waal HA, Sanz-Arigita EJ. Resting-state networks in awake five- to eight-year old children. Human Brain Mapping. 33: 1189-201. PMID 21520347 DOI: 10.1002/hbm.21280  1
2012 den Hollander B, Schouw M, Groot P, Huisman H, Caan M, Barkhof F, Reneman L. Preliminary evidence of hippocampal damage in chronic users of ecstasy. Journal of Neurology, Neurosurgery, and Psychiatry. 83: 83-5. PMID 21444322 DOI: 10.1136/jnnp.2010.228387  1
2012 Schuitemaker A, van der Doef TF, Boellaard R, van der Flier WM, Yaqub M, Windhorst AD, Barkhof F, Jonker C, Kloet RW, Lammertsma AA, Scheltens P, van Berckel BN. Microglial activation in healthy aging. Neurobiology of Aging. 33: 1067-72. PMID 21051106 DOI: 10.1016/j.neurobiolaging.2010.09.016  1
2012 Buis DR, Vandertop WP, Bot JCJ, Barkhof F, Knol DL, Lagerwaard FJ, Slotman BJ, Van Den Berg R. Further examination of diagnostic performance in the context of a fellows' journal club article: Reply American Journal of Neuroradiology. 33: E98. DOI: 10.3174/ajnr.A3188  0.88
2012 Koeller KK, Barkhof F. Demyelinating diseases Diseases of the Brain, Head and Neck, Spine 2012-2015: Diagnostic Imaging and Interventional Techniques. 50-57. DOI: 10.1007/978-88-470-2628-5_9  0.88
2011 Frederiksen KS, Garde E, Skimminge A, Barkhof F, Scheltens P, van Straaten EC, Fazekas F, Baezner H, Verdelho A, Ferro JM, Erkinjuntti T, Jokinen H, Wahlund LO, O'Brien JT, Basile AM, et al. Corpus callosum tissue loss and development of motor and global cognitive impairment: the LADIS study. Dementia and Geriatric Cognitive Disorders. 32: 279-86. PMID 22262017 DOI: 10.1159/000334949  1
2011 van den Elskamp IJ, Knol DL, Uitdehaag BM, Barkhof F. Modeling MR imaging enhancing-lesion volumes in multiple sclerosis: application in clinical trials. Ajnr. American Journal of Neuroradiology. 32: 2093-7. PMID 22051810 DOI: 10.3174/ajnr.A2691  0.72
2011 Kappos L, Li D, Calabresi PA, O'Connor P, Bar-Or A, Barkhof F, Yin M, Leppert D, Glanzman R, Tinbergen J, Hauser SL. Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial. Lancet. 378: 1779-87. PMID 22047971 DOI: 10.1016/S0140-6736(11)61649-8  1
2011 Steenweg ME, Pouwels PJ, Wolf NI, van Wieringen WN, Barkhof F, van der Knaap MS. Leucoencephalopathy with brainstem and spinal cord involvement and high lactate: quantitative magnetic resonance imaging. Brain : a Journal of Neurology. 134: 3333-41. PMID 22006980 DOI: 10.1093/brain/awr254  1
2011 Schott JM, Warren JD, Barkhof F, Rossor MN, Fox NC. Suspected early dementia. Bmj (Clinical Research Ed.). 343: d5568. PMID 21933826 DOI: 10.1136/bmj.d5568  1
2011 De Bie HM, Oostrom KJ, Boersma M, Veltman DJ, Barkhof F, Delemarre-van de Waal HA, van den Heuvel MP. Global and regional differences in brain anatomy of young children born small for gestational age. Plos One. 6: e24116. PMID 21931650 DOI: 10.1371/journal.pone.0024116  1
2011 Hazewinkel M, Barkhof F. Imaging Alzheimer in 2011. Neuroradiology. 53: S145-7. PMID 21863421 DOI: 10.1007/s00234-011-0931-6  0.88
2011 Hartung HP, Freedman MS, Polman CH, Edan G, Kappos L, Miller DH, Montalbán X, Barkhof F, Petkau J, White R, Sahajpal V, Knappertz V, Beckmann K, Lanius V, Sandbrink R, et al. Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndrome. Neurology. 77: 835-43. PMID 21849647 DOI: 10.1212/WNL.0b013e31822c90d7  1
2011 Koedam EL, Lehmann M, van der Flier WM, Scheltens P, Pijnenburg YA, Fox N, Barkhof F, Wattjes MP. Visual assessment of posterior atrophy development of a MRI rating scale. European Radiology. 21: 2618-25. PMID 21805370 DOI: 10.1007/s00330-011-2205-4  1
2011 Jack CR, Barkhof F, Bernstein MA, Cantillon M, Cole PE, Decarli C, Dubois B, Duchesne S, Fox NC, Frisoni GB, Hampel H, Hill DL, Johnson K, Mangin JF, Scheltens P, et al. Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 474-485.e4. PMID 21784356 DOI: 10.1016/j.jalz.2011.04.007  1
2011 Cover KS, van Schijndel RA, van Dijk BW, Redolfi A, Knol DL, Frisoni GB, Barkhof F, Vrenken H. Assessing the reproducibility of the SienaX and Siena brain atrophy measures using the ADNI back-to-back MP-RAGE MRI scans. Psychiatry Research. 193: 182-90. PMID 21764565 DOI: 10.1016/j.pscychresns.2011.02.012  0.8
2011 Kilsdonk ID, Barkhof F, Wattjes MP. 2010 revisions to McDonald criteria for diagnosis of multiple sclerosis: impact of 3-Tesla magnetic resonance imaging. Annals of Neurology. 70: 182-3. PMID 21710623 DOI: 10.1002/ana.22490  0.84
2011 Ropele S, de Graaf W, Khalil M, Wattjes MP, Langkammer C, Rocca MA, Rovira A, Palace J, Barkhof F, Filippi M, Fazekas F. MRI assessment of iron deposition in multiple sclerosis. Journal of Magnetic Resonance Imaging : Jmri. 34: 13-21. PMID 21698703 DOI: 10.1002/jmri.22590  0.84
2011 Uitdehaag BM, Barkhof F, Coyle PK, Gardner JD, Jeffery DR, Mikol DD. The changing face of multiple sclerosis clinical trial populations. Current Medical Research and Opinion. 27: 1529-37. PMID 21671851 DOI: 10.1185/03007995.2011.591370  1
2011 Ryberg C, Rostrup E, Paulson OB, Barkhof F, Scheltens P, van Straaten EC, van der Flier WM, Fazekas F, Schmidt R, Ferro JM, Baezner H, Erkinjuntti T, Jokinen H, Wahlund LO, Poggesi A, et al. Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: a 3-year follow-up of the LADIS study cohort. Journal of the Neurological Sciences. 307: 100-5. PMID 21621224 DOI: 10.1016/j.jns.2011.05.002  1
2011 Smolders J, Hupperts R, Barkhof F, Grimaldi LM, Holmoy T, Killestein J, Rieckmann P, Schluep M, Vieth R, Hostalek U, Ghazi-Visser L, Beelke M. Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial. Journal of the Neurological Sciences. 311: 44-9. PMID 21620416 DOI: 10.1016/j.jns.2011.04.013  0.68
2011 Sombekke MH, Jafari N, Bendfeldt K, Mueller-Lenke N, Radue EW, Naegelin Y, Kappos L, Matthews PM, Polman CH, Barkhof F, Hintzen R, Geurts JJ. No influence of KIF1B on neurodegenerative markers in multiple sclerosis. Neurology. 76: 1843-5. PMID 21606458 DOI: 10.1212/WNL.0b013e31821cccd4  1
2011 Roosendaal SD, Bendfeldt K, Vrenken H, Polman CH, Borgwardt S, Radue EW, Kappos L, Pelletier D, Hauser SL, Matthews PM, Barkhof F, Geurts JJ. Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 1098-106. PMID 21586487 DOI: 10.1177/1352458511404916  1
2011 Khatri B, Barkhof F, Comi G, Hartung HP, Kappos L, Montalban X, Pelletier J, Stites T, Wu S, Holdbrook F, Zhang-Auberson L, Francis G, Cohen JA. Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study. The Lancet. Neurology. 10: 520-9. PMID 21571593 DOI: 10.1016/S1474-4422(11)70099-0  0.48
2011 Goos JD, van der Flier WM, Knol DL, Pouwels PJ, Scheltens P, Barkhof F, Wattjes MP. Clinical relevance of improved microbleed detection by susceptibility-weighted magnetic resonance imaging. Stroke; a Journal of Cerebral Circulation. 42: 1894-900. PMID 21566235 DOI: 10.1161/STROKEAHA.110.599837  1
2011 Seewann A, Vrenken H, Kooi EJ, van der Valk P, Knol DL, Polman CH, Pouwels PJ, Barkhof F, Geurts JJ. Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 1202-10. PMID 21561955 DOI: 10.1177/1352458511406575  1
2011 Jokinen H, Gouw AA, Madureira S, Ylikoski R, van Straaten EC, van der Flier WM, Barkhof F, Scheltens P, Fazekas F, Schmidt R, Verdelho A, Ferro JM, Pantoni L, Inzitari D, Erkinjuntti T, et al. Incident lacunes influence cognitive decline: the LADIS study. Neurology. 76: 1872-8. PMID 21543730 DOI: 10.1212/WNL.0b013e31821d752f  1
2011 Vermeulen RJ, Peeters-Scholte C, Van Vugt JJ, Van Vught JJ, Barkhof F, Rizzu P, van der Schoor SR, van der Knaap MS. Fetal origin of brain damage in 2 infants with a COL4A1 mutation: fetal and neonatal MRI. Neuropediatrics. 42: 1-3. PMID 21500141 DOI: 10.1055/s-0031-1275343  1
2011 Sombekke MH, Vellinga MM, Uitdehaag BM, Barkhof F, Polman CH, Arteta D, Tejedor D, Martinez A, Crusius JB, Peña AS, Geurts JJ, Vrenken H. Genetic correlations of brain lesion distribution in multiple sclerosis: an exploratory study. Ajnr. American Journal of Neuroradiology. 32: 695-703. PMID 21436341 DOI: 10.3174/ajnr.A2352  1
2011 Liguori M, Meier DS, Hildenbrand P, Healy BC, Chitnis T, Baruch NF, Khoury SJ, Weiner HL, Bakshi R, Barkhof F, Guttmann CR. One year activity on subtraction MRI predicts subsequent 4 year activity and progression in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 1125-31. PMID 21429902 DOI: 10.1136/jnnp.2011.242115  1
2011 Valsasina P, Rocca MA, Absinta M, Sormani MP, Mancini L, De Stefano N, Rovira A, Gass A, Enzinger C, Barkhof F, Wegner C, Matthews PM, Filippi M. A multicentre study of motor functional connectivity changes in patients with multiple sclerosis. The European Journal of Neuroscience. 33: 1256-63. PMID 21375601 DOI: 10.1111/j.1460-9568.2011.07623.x  1
2011 Hohlfeld R, Barkhof F, Polman C. Future clinical challenges in multiple sclerosis: Relevance to sphingosine 1-phosphate receptor modulator therapy. Neurology. 76: S28-37. PMID 21339488 DOI: 10.1212/WNL.0b013e31820db40f  0.6
2011 Belhawi SM, Hoefnagels FW, Baaijen JC, Aliaga ES, Reijneveld JC, Heimans JJ, Barkhof F, Vandertop WP, Hamer PC. Early postoperative MRI overestimates residual tumour after resection of gliomas with no or minimal enhancement. European Radiology. 21: 1526-34. PMID 21331595 DOI: 10.1007/s00330-011-2081-y  1
2011 Vennegoor A, Wattjes MP, van Munster ET, Kriekaart RL, van Oosten BW, Barkhof F, Killestein J, Polman CH. Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS. Neurology. 76: 574-6. PMID 21300973 DOI: 10.1212/WNL.0b013e31820b7644  1
2011 Filippi M, Rocca MA, Barkhof F, Bakshi R, Fazekas F, Khan O, Pelletier D, Rovira A, Simon J. Multiple sclerosis and chronic cerebrospinal venous insufficiency: the neuroimaging perspective. Ajnr. American Journal of Neuroradiology. 32: 424-7. PMID 21292801 DOI: 10.3174/ajnr.A2348  1
2011 van der Voorn JP, Pouwels PJ, Powers JM, Kamphorst W, Martin JJ, Troost D, Spreeuwenberg MD, Barkhof F, van der Knaap MS. Correlating quantitative MR imaging with histopathology in X-linked adrenoleukodystrophy. Ajnr. American Journal of Neuroradiology. 32: 481-9. PMID 21273354 DOI: 10.3174/ajnr.A2327  1
2011 Geurts JJ, Roosendaal SD, Calabrese M, Ciccarelli O, Agosta F, Chard DT, Gass A, Huerga E, Moraal B, Pareto D, Rocca MA, Wattjes MP, Yousry TA, Uitdehaag BM, Barkhof F, et al. Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology. 76: 418-24. PMID 21209373 DOI: 10.1212/WNL.0b013e31820a0cc4  1
2011 Barkhof F, Pouwels PJ, Wattjes MP. The Holy Grail in diagnostic neuroradiology: 3T or 3D? European Radiology. 21: 449-56. PMID 21181406 DOI: 10.1007/s00330-010-2034-x  0.84
2011 Rovaris M, Rocca MA, Barkhof F, Calabrese M, De Stefano N, Khalil M, Fazekas F, Fisniku L, Gallo P, Miller DH, Montalban X, Polman C, Rovira A, Sombekke MH, Sormani MP, et al. Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: a large-scale, multicentre study. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 319-26. PMID 21159719 DOI: 10.1177/1352458510388824  0.6
2011 Wattjes MP, van Oosten BW, de Graaf WL, Seewann A, Bot JC, van den Berg R, Uitdehaag BM, Polman CH, Barkhof F. No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and flow-quantification study. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 429-35. PMID 20980483 DOI: 10.1136/jnnp.2010.223479  1
2011 Willemse RB, Pouwels PJ, Barkhof F, Vandertop WP. Localisation of the central sulcus region in glioma patients with three-dimensional fluid-attenuated inversion recovery and volume rendering: comparison with functional and conventional magnetic resonance. British Journal of Neurosurgery. 25: 210-7. PMID 20979436 DOI: 10.3109/02688697.2010.522742  0.8
2011 Gouw AA, Seewann A, van der Flier WM, Barkhof F, Rozemuller AM, Scheltens P, Geurts JJ. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 126-35. PMID 20935330 DOI: 10.1136/jnnp.2009.204685  1
2011 Oudega ML, van Exel E, Wattjes MP, Comijs HC, Scheltens P, Barkhof F, Eikelenboom P, de Craen AJ, Beekman AT, Stek ML. White matter hyperintensities, medial temporal lobe atrophy, cortical atrophy, and response to electroconvulsive therapy in severely depressed elderly patients. The Journal of Clinical Psychiatry. 72: 104-12. PMID 20816035 DOI: 10.4088/JCP.08m04989blu  1
2011 Bodini B, Battaglini M, De Stefano N, Khaleeli Z, Barkhof F, Chard D, Filippi M, Montalban X, Polman C, Rovaris M, Rovira A, Samson R, Miller D, Thompson A, Ciccarelli O. T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 72-7. PMID 20627965 DOI: 10.1136/jnnp.2009.201574  1
2011 Wattjes MP, Geurts JJG, Barkhof F. Imaging of gray matter lesions in multiple sclerosis Multiple Sclerosis Therapeutics, Fourth Edition. 165-174. DOI: 10.1017/CBO9781139023986.016  0.88
2010 Sanz-Arigita EJ, Schoonheim MM, Damoiseaux JS, Rombouts SA, Maris E, Barkhof F, Scheltens P, Stam CJ. Loss of 'small-world' networks in Alzheimer's disease: graph analysis of FMRI resting-state functional connectivity. Plos One. 5: e13788. PMID 21072180 DOI: 10.1371/journal.pone.0013788  1
2010 Polvikoski TM, van Straaten EC, Barkhof F, Sulkava R, Aronen HJ, Niinistö L, Oinas M, Scheltens P, Erkinjuntti T, Kalaria RN. Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old. Neurology. 75: 2071-8. PMID 21048201 DOI: 10.1212/WNL.0b013e318200d6f9  1
2010 van der Voort LF, Vennegoor A, Visser A, Knol DL, Uitdehaag BM, Barkhof F, Oudejans CB, Polman CH, Killestein J. Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MS. Neurology. 75: 1228-33. PMID 20921509 DOI: 10.1212/WNL.0b013e3181f6c556  1
2010 Worthington V, Killestein J, Eikelenboom MJ, Teunissen CE, Barkhof F, Polman CH, Uitdehaag BM, Petzold A. Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency. Neurology. 75: 1617-22. PMID 20881272 DOI: 10.1212/WNL.0b013e3181fb449e  1
2010 Steenweg ME, Vanderver A, Blaser S, Bizzi A, de Koning TJ, Mancini GM, van Wieringen WN, Barkhof F, Wolf NI, van der Knaap MS. Magnetic resonance imaging pattern recognition in hypomyelinating disorders. Brain : a Journal of Neurology. 133: 2971-82. PMID 20881161 DOI: 10.1093/brain/awq257  1
2010 Lukas C, Minneboo A, de Groot V, Moraal B, Knol DL, Polman CH, Barkhof F, Vrenken H. Early central atrophy rate predicts 5 year clinical outcome in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 81: 1351-6. PMID 20826873 DOI: 10.1136/jnnp.2009.199968  1
2010 Tolboom N, Koedam EL, Schott JM, Yaqub M, Blankenstein MA, Barkhof F, Pijnenburg YA, Lammertsma AA, Scheltens P, van Berckel BN. Dementia mimicking Alzheimer's disease Owing to a tau mutation: CSF and PET findings. Alzheimer Disease and Associated Disorders. 24: 303-7. PMID 20683187 DOI: 10.1097/WAD.0b013e3181cf35ec  1
2010 Koedam EL, Van der Flier WM, Barkhof F, Koene T, Scheltens P, Pijnenburg YA. Clinical characteristics of patients with frontotemporal dementia with and without lobar atrophy on MRI. Alzheimer Disease and Associated Disorders. 24: 242-7. PMID 20683185 DOI: 10.1097/WAD.0b013e3181cfe326  1
2010 Bouwman FH, Verwey NA, Klein M, Kok A, Blankenstein MA, Sluimer JD, Barkhof F, van der Flier WM, Scheltens P. New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic population. Dementia and Geriatric Cognitive Disorders. 30: 1-7. PMID 20606438 DOI: 10.1159/000315542  1
2010 Goos JD, Henneman WJ, Sluimer JD, Vrenken H, Sluimer IC, Barkhof F, Blankenstein MA, Scheltens PH, van der Flier WM. Incidence of cerebral microbleeds: a longitudinal study in a memory clinic population. Neurology. 74: 1954-60. PMID 20548041 DOI: 10.1212/WNL.0b013e3181e396ea  1
2010 Nielsen JM, Uitdehaag BM, Korteweg T, Barkhof F, Polman CH. Performance of the Swanton multiple sclerosis criteria for dissemination in space. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 985-7. PMID 20547588 DOI: 10.1177/1352458510369244  1
2010 Tolboom N, van der Flier WM, Boverhoff J, Yaqub M, Wattjes MP, Raijmakers PG, Barkhof F, Scheltens P, Herholz K, Lammertsma AA, van Berckel BN. Molecular imaging in the diagnosis of Alzheimer's disease: visual assessment of [11C]PIB and [18F]FDDNP PET images. Journal of Neurology, Neurosurgery, and Psychiatry. 81: 882-4. PMID 20543188 DOI: 10.1136/jnnp.2009.194779  1
2010 De Stefano N, Giorgio A, Battaglini M, Rovaris M, Sormani MP, Barkhof F, Korteweg T, Enzinger C, Fazekas F, Calabrese M, Dinacci D, Tedeschi G, Gass A, Montalban X, Rovira A, et al. Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology. 74: 1868-76. PMID 20530323 DOI: 10.1212/WNL.0b013e3181e24136  1
2010 Pagani E, Hirsch JG, Pouwels PJ, Horsfield MA, Perego E, Gass A, Roosendaal SD, Barkhof F, Agosta F, Rovaris M, Caputo D, Giorgio A, Palace J, Marino S, De Stefano N, et al. Intercenter differences in diffusion tensor MRI acquisition. Journal of Magnetic Resonance Imaging : Jmri. 31: 1458-68. PMID 20512899 DOI: 10.1002/jmri.22186  1
2010 Schaafsma JD, Velthuis BK, Majoie CB, van den Berg R, Brouwer PA, Barkhof F, Eshghi O, de Kort GA, Lo RT, Witkamp TD, Sprengers ME, van Walderveen MA, Bot JC, Sanchez E, Vandertop WP, et al. Intracranial aneurysms treated with coil placement: test characteristics of follow-up MR angiography--multicenter study. Radiology. 256: 209-18. PMID 20505063 DOI: 10.1148/radiol.10091528  1
2010 Moraal B, van den Elskamp IJ, Knol DL, Uitdehaag BM, Geurts JJ, Vrenken H, Pouwels PJ, van Schijndel RA, Meier DS, Guttmann CR, Barkhof F. Long-interval T2-weighted subtraction magnetic resonance imaging: a powerful new outcome measure in multiple sclerosis trials. Annals of Neurology. 67: 667-75. PMID 20437564 DOI: 10.1002/ana.21958  1
2010 Roosendaal SD, Hulst HE, Vrenken H, Feenstra HE, Castelijns JA, Pouwels PJ, Barkhof F, Geurts JJ. Structural and functional hippocampal changes in multiple sclerosis patients with intact memory function. Radiology. 255: 595-604. PMID 20413769 DOI: 10.1148/radiol.10091433  1
2010 Schoonheim MM, Geurts JJ, Barkhof F. The limits of functional reorganization in multiple sclerosis. Neurology. 74: 1246-7. PMID 20404304 DOI: 10.1212/WNL.0b013e3181db9957  1
2010 Staekenborg SS, de Waal H, Admiraal-Behloul F, Barkhof F, Reiber JH, Scheltens P, Pijnenburg YA, Vrenken H, van der Flier WM. Neurological signs in relation to white matter hyperintensity volumes in memory clinic patients. Dementia and Geriatric Cognitive Disorders. 29: 301-8. PMID 20389072 DOI: 10.1159/000254791  1
2010 Khan O, Filippi M, Freedman MS, Barkhof F, Dore-Duffy P, Lassmann H, Trapp B, Bar-Or A, Zak I, Siegel MJ, Lisak R. Chronic cerebrospinal venous insufficiency and multiple sclerosis. Annals of Neurology. 67: 286-90. PMID 20373339 DOI: 10.1002/ana.22001  0.48
2010 Roosendaal SD, Schoonheim MM, Hulst HE, Sanz-Arigita EJ, Smith SM, Geurts JJ, Barkhof F. Resting state networks change in clinically isolated syndrome. Brain : a Journal of Neurology. 133: 1612-21. PMID 20356855 DOI: 10.1093/brain/awq058  1
2010 van den Elskamp IJ, Knol DL, Vrenken H, Karas G, Meijerman A, Filippi M, Kappos L, Fazekas F, Wagner K, Pohl C, Sandbrink R, Polman CH, Uitdehaag BM, Barkhof F. Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 660-9. PMID 20350960 DOI: 10.1177/1352458510364630  1
2010 Moraal B, Wattjes MP, Geurts JJ, Knol DL, van Schijndel RA, Pouwels PJ, Vrenken H, Barkhof F. Improved detection of active multiple sclerosis lesions: 3D subtraction imaging. Radiology. 255: 154-63. PMID 20308453 DOI: 10.1148/radiol.09090814  1
2010 Schmidt R, Ropele S, Ferro J, Madureira S, Verdelho A, Petrovic K, Gouw A, van der Flier WM, Enzinger C, Pantoni L, Inzitari D, Erkinjuntti T, Scheltens P, Wahlund LO, Waldemar G, ... ... Barkhof F, et al. Diffusion-weighted imaging and cognition in the leukoariosis and disability in the elderly study. Stroke; a Journal of Cerebral Circulation. 41: e402-8. PMID 20203319 DOI: 10.1161/STROKEAHA.109.576629  1
2010 Barkhof F, Hulst HE, Drulovic J, Uitdehaag BM, Matsuda K, Landin R. Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant? Neurology. 74: 1033-40. PMID 20200338 DOI: 10.1212/WNL.0b013e3181d7d651  0.8
2010 Lazzarino G, Amorini AM, Eikelenboom MJ, Killestein J, Belli A, Di Pietro V, Tavazzi B, Barkhof F, Polman CH, Uitdehaag BM, Petzold A. Cerebrospinal fluid ATP metabolites in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 549-54. PMID 20194579 DOI: 10.1177/1352458510364196  1
2010 Simon B, Schmidt S, Lukas C, Gieseke J, Träber F, Knol DL, Willinek WA, Geurts JJ, Schild HH, Barkhof F, Wattjes MP. Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla. European Radiology. 20: 1675-83. PMID 20094887 DOI: 10.1007/s00330-009-1705-y  1
2010 Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, Montalban X, Pelletier J, Capra R, Gallo P, Izquierdo G, Tiel-Wilck K, de Vera A, Jin J, Stites T, Wu S, et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. The New England Journal of Medicine. 362: 402-15. PMID 20089954 DOI: 10.1056/NEJMoa0907839  0.48
2010 Mesaros S, Rocca M, Sormani M, Valsasina P, Markowitz C, De Stefano N, Montalban X, Barkhof F, Ranjeva J, Sailer M, Kappos L, Comi G, Filippi M. Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up study. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 325-31. PMID 20086023 DOI: 10.1177/1352458509358713  1
2010 Montalban X, Tintoré M, Swanton J, Barkhof F, Fazekas F, Filippi M, Frederiksen J, Kappos L, Palace J, Polman C, Rovaris M, de Stefano N, Thompson A, Yousry T, Rovira A, et al. MRI criteria for MS in patients with clinically isolated syndromes. Neurology. 74: 427-34. PMID 20054006 DOI: 10.1212/WNL.0b013e3181cec45c  0.6
2010 van den Elskamp IJ, Boden B, Dattola V, Knol DL, Filippi M, Kappos L, Fazekas F, Wagner K, Pohl C, Sandbrink R, Polman CH, Uitdehaag BM, Barkhof F. Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis. Neuroradiology. 52: 875-81. PMID 20049424 DOI: 10.1007/s00234-009-0645-1  1
2010 Staekenborg SS, Su T, van Straaten EC, Lane R, Scheltens P, Barkhof F, van der Flier WM. Behavioural and psychological symptoms in vascular dementia; differences between small- and large-vessel disease. Journal of Neurology, Neurosurgery, and Psychiatry. 81: 547-51. PMID 19965852 DOI: 10.1136/jnnp.2009.187500  1
2010 Vrenken H, Seewann A, Knol DL, Polman CH, Barkhof F, Geurts JJ. Diffusely abnormal white matter in progressive multiple sclerosis: in vivo quantitative MR imaging characterization and comparison between disease types. Ajnr. American Journal of Neuroradiology. 31: 541-8. PMID 19850760 DOI: 10.3174/ajnr.A1839  1
Show low-probability matches.